Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010156	s-hcrp	mg/l (mg/l)	5106	6489	0.00%
3010156	s-hcrp	— (—)	4773	6005	100.00%	Distribution not available
3010156	s-hs-crp	mg/l (mg/l)	3606	7574	0.04%
3010156	s-ucrp	mg/l (mg/l)	1937	3244	0.00%
3010156	p-hs-crp	mg/l (mg/l)	492	1302	0.00%
3010156	s-hs-crp	— (—)	355	479	100.00%	Distribution not available
3010156	s-ucrp	— (—)	351	410	100.00%	Distribution not available
3010156	s-hscrp	mg/l (mg/l)	287	344	0.00%
3010156	s-c-reaktiivinenproteiini,herkkä	mg/l (—)	117	120	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,herkkä	mg/l (—)	107	148	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,vieritutkimus	mg/l (—)	80	85	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,vieritutkimusnordlab	mg/l (—)	74	82	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,pika	mg/l (—)	71	81	100.00%	Distribution not available
3010156	s-c-reaktiivinenproteiini,pika	mg/l (—)	66	77	100.00%	Distribution not available
3010156	p-hs-crp	— (—)	52	65	100.00%	Distribution not available
3010156	s-hscrp	— (—)	14	15	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Obesity, other/unspecified

1327

6268

2.21

147.10

2.2

1.6

5.11

3.60

mg/l

3.47

1246

4327

Other nutritional deficiencies

2208

11764

1.81

140.64

2.0

1.6

5.12

3.62

mg/l

6.73

2039

8087

Depression

2999

12489

1.66

132.49

1.6

3.70

3.86

mg/l

0.47

2465

8634

Obesity

2074

11438

1.80

128.18

2.0

1.6

5.17

3.62

mg/l

6.83

1943

7876

Obesity and other hyperalimentation

2078

11470

1.79

127.37

2.0

1.6

5.17

3.61

mg/l

6.90

1946

7900

Mood [affective] disorders

3088

12611

1.62

121.99

1.7

1.6

3.73

3.86

mg/l

0.33

2530

8731

Mood disorders

3090

12614

1.61

121.41

1.6

3.75

3.85

mg/l

0.25

2530

8735

Obesity due to excess calories

1593

8670

1.89

117.10

2.0

1.6

5.15

3.64

mg/l

4.81

1497

5966

Myocarditis

292

689

4.74

115.65

11.2

1.4

3.23

3.55

mg/l

0.22

280

465

Recurrent or chronic depression

1512

5688

1.92

109.93

1.6

1.7

3.42

3.92

mg/l

1.41

1244

3782

Any death

228

6056

0.26

98.14

1.9

1.7

9.61

3.67

mg/l

4.05

209

4455

Nonorganic sleeping disorders, excluding more controls

747

3342

2.34

95.17

1.6

1.7

3.15

3.88

mg/l

1.57

632

2219

Behavioural syndromes associated with physiological disturbances and physical factors

2708

12597

1.55

91.46

1.6

3.39

3.92

mg/l

3.04

2097

8883

Mood disorders, excluding more controls

2768

10814

1.55

91.39

1.7

1.6

3.79

3.82

mg/l

0.05

2275

7403

Neurotic, stress-related and somatoform disorders

2708

12452

1.55

90.55

1.7

1.6

3.90

3.82

mg/l

0.17

2169

8694

Sleep apnoea

2469

10262

1.58

90.12

1.9

1.6

5.10

3.54

mg/l

5.98

2153

7223

Sleep apnoea, including avohilmo

2661

10745

1.56

89.93

1.8

1.6

4.96

3.52

mg/l

5.97

2289

7514

Anxiety (asthma-related co-morbidities)

2071

9979

1.64

89.48

1.6

3.64

3.91

mg/l

0.76

1648

6805

All anxiety disorders

2119

10518

1.63

88.78

1.6

3.64

3.87

mg/l

0.65

1684

7264

Anxiety disorders

2713

12488

1.54

88.55

1.7

1.6

3.91

3.81

mg/l

0.21

2173

8723

Sleep disorders

2616

12434

1.55

87.62

1.5

1.6

3.41

3.94

mg/l

2.95

2018

8774

Sleep disorders (combined)

3114

11107

1.49

83.47

1.7

1.6

4.19

3.60

mg/l

1.67

2490

7556

Special screening examination for infectious and parasitic diseases

1103

4429

1.90

77.04

1.5

1.6

3.22

3.60

mg/l

0.80

748

2887

Insomnia

2553

12525

1.51

76.69

1.5

1.6

3.35

3.92

mg/l

3.39

1962

8851

Sarcoidosis

445

1742

2.69

76.49

7.7

1.5

3.94

4.18

mg/l

0.17

406

1291

Anxiety disorders, excluding more controls

2443

10575

1.53

76.19

1.7

1.6

3.93

3.75

mg/l

0.36

1971

7224

Generalized anxiety disorder

670

3160

2.22

75.34

1.5

1.6

3.20

4.04

mg/l

1.84

537

2100

Nonorganic sleeping disorders

747

3682

2.11

74.47

1.6

1.7

3.15

4.10

mg/l

2.67

632

2604

Other antidepressants

2775

9724

1.48

71.69

1.6

4.04

3.90

mg/l

0.26

2195

6605

Other anxiety disorders

1565

8564

1.62

65.43

1.6

3.53

3.87

mg/l

0.98

1253

5818

Selective serotonin reuptake inhibitors

2672

9735

1.45

62.50

1.6

3.67

3.90

mg/l

0.60

2089

6613

Certain disorders involving the immune mechanism

533

2624

2.10

53.18

6.7

1.5

4.24

4.02

mg/l

0.18

478

1918

Depression or dysthymia

1768

6665

1.48

47.10

1.7

1.6

3.57

3.89

mg/l

0.70

1414

4493

Hyperkinetic disorders, excluding more controls

455

2181

2.08

43.39

1.4

1.6

3.66

3.84

mg/l

0.18

359

1292

Chronic diseases of tonsils and adenoids

2213

10261

1.38

40.68

1.6

3.74

3.75

mg/l

0.01

1618

7235

Episodal and paroxysmal disorders

2875

11194

1.32

38.05

1.7

1.6

4.20

3.56

mg/l

1.80

2286

7629

Continuous positive airway pressure

525

2414

1.88

37.52

2.2

1.4

4.74

2.94

mg/l

3.54

469

1582

Restless leg syndrome

356

1722

2.14

37.50

1.7

3.23

4.02

mg/l

0.86

311

1278

Diagnoses used for exclusion with ILD

530

2929

1.85

37.25

6.8

1.5

5.23

3.96

mg/l

1.19

485

2150

Triptan medication for migraine, single purchase ok

2223

11245

1.36

36.97

1.7

1.6

3.82

3.89

mg/l

0.12

1631

8008

Migraine, single triptan purchase ok & required. ICD-code if available is included

2223

11245

1.36

36.97

1.7

1.6

3.82

3.89

mg/l

0.12

1631

8008

Depression medications

1144

3790

1.55

36.11

1.6

1.3

4.17

3.16

mg/l

3.19

894

2213

Other sleep disorders

304

1474

2.13

31.88

1.8

1.6

2.88

3.63

mg/l

1.27

268

1005

Disorder of the sleep-wake schedule

258

4.10

31.54

1.6

3.24

3.86

mg/l

0.37

176

Sleep disorders, other/unspecified

160

593

2.90

31.50

1.7

1.9

3.19

4.77

mg/l

0.79

146

416

Other diseases of upper respiratory tract

2645

10726

1.30

31.09

1.7

1.6

4.09

3.79

mg/l

0.64

1945

7604

Benzodiazepine use

2483

13292

1.30

30.86

1.7

1.6

3.96

3.84

mg/l

0.24

2018

9395

KRA_PSY_EATING, excluding more controls

332

1695

2.03

30.09

1.6

1.5

3.59

3.96

mg/l

0.30

253

1025

Adjustment and management of implanted device

301

1494

2.05

29.30

8.5

1.5

4.25

3.69

mg/l

0.36

272

1090

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2596

0.30

28.10

1.7

6.23

3.97

mg/l

1.02

1898

Persistent mood disorders

494

2912

1.73

28.10

1.7

1.6

3.70

3.98

mg/l

0.32

428

2028

Hyperkinetic disorders

455

2575

1.79

28.06

1.4

1.6

3.66

3.86

mg/l

0.21

359

1708

Postmenopausal atrophic vaginitis

568

1861

1.72

28.02

1.6

1.7

2.87

4.16

mg/l

2.96

414

1405

Hypothyroidism, other/unspecified

2176

11101

1.30

27.48

1.8

1.6

4.10

3.84

mg/l

0.60

1729

7859

Disorders of the thyroid gland

2300

11699

1.29

27.44

1.8

1.6

4.02

3.88

mg/l

0.30

1818

8285

Disturbance of activity and attention

435

2450

1.80

27.41

1.4

1.6

3.60

3.72

mg/l

0.12

342

1611

Stroke, including SAH

474

5733

0.59

27.05

1.7

3.80

3.96

mg/l

0.12

372

4240

Personality disorders, excluding more controls

775

5142

1.54

26.95

1.6

3.60

3.92

mg/l

0.57

655

3384

Medical observation and evaluation for suspected diseases and conditions

1729

6621

1.35

26.90

1.8

1.6

4.23

3.69

mg/l

1.02

1346

4509

Hypothyreosis and Thyroxine purchase for inclusion criteria

2238

11473

1.29

26.68

1.8

1.6

4.10

3.79

mg/l

0.84

1779

8144

Diabetes, insulin treatment (Kela reimbursement)

1457

11823

0.74

26.62

1.9

1.6

4.96

3.74

mg/l

4.46

1318

8459

Migraine

1456

8753

1.37

26.42

1.7

1.6

3.69

3.59

mg/l

0.18

1098

5952

Symptoms and signs involving the circulatory and respiratory systems

2711

10856

1.26

25.57

1.8

1.5

4.51

3.53

mg/l

2.94

2068

7526

Other extrapyramidal and movement disorders in other diseases

484

2911

1.69

25.49

1.7

3.23

3.83

mg/l

0.88

405

2139

Hypothyroidism and >3 levothyroxin purchases

931

3600

1.49

25.42

1.8

1.3

4.08

3.19

mg/l

2.17

737

2132

Hypothyroidism, levothyroxine purchases

931

3600

1.49

25.42

1.8

1.3

4.08

3.19

mg/l

2.17

737

2132

Hypothyroidism (congenital or acquired)

932

3616

1.48

24.90

1.8

1.3

4.04

3.18

mg/l

2.03

737

2137

Headache

1781

10940

1.31

24.87

1.7

1.5

4.03

3.64

mg/l

1.00

1377

7614

Stroke, excluding SAH

423

5183

0.59

24.86

1.7

3.44

4.04

mg/l

0.67

338

3845

Phobic anxiety disorders

438

2594

1.73

24.64

1.5

1.6

3.99

4.05

mg/l

0.05

354

1702

Obesity related asthma

803

5471

1.49

24.46

2.0

1.7

6.05

3.57

mg/l

3.29

730

3962

Chronic rhinitis, nasopharyngitis and pharyngitis

783

5308

1.50

24.45

1.6

3.96

3.66

mg/l

0.29

596

3814

Other chronic obstructive pulmonary disease, including avohilmo

358

5128

0.57

24.09

1.6

1.7

8.11

3.75

mg/l

4.22

307

3769

Disorders of conjunctiva

2067

13090

1.28

23.64

1.7

1.6

3.76

3.82

mg/l

0.11

1525

9351

Triptan medication for migraine, min. 3 purchases

1711

10084

1.31

23.26

1.7

1.6

3.53

3.90

mg/l

0.94

1259

7232

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1537

13672

0.76

23.13

1.9

1.6

6.29

3.51

mg/l

9.35

1276

9724

Ischaemic Stroke, excluding all haemorrhages

374

4724

0.58

23.04

1.7

3.40

4.05

mg/l

0.67

298

3508

Conjunctivitis

1933

12711

1.28

22.65

1.6

3.77

3.83

mg/l

0.10

1427

9064

Abnormalities of heart beat

794

5374

1.47

22.46

2.0

1.6

4.10

3.50

mg/l

0.82

611

3747

Pain in joint

1522

7378

1.33

22.40

1.7

1.6

4.32

3.49

mg/l

2.05

1184

5005

Periodontitis

1393

12260

0.75

22.38

1.7

5.94

3.63

mg/l

4.43

1130

8895

Chronic sinusitis

1006

7261

1.40

22.15

1.8

1.6

4.03

3.81

mg/l

0.33

795

5221

Chronic periodontitis, including avohilmo

1393

12228

0.76

21.63

1.8

1.7

5.92

3.63

mg/l

4.36

1130

8876

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1424

11213

0.76

21.48

1.9

1.6

4.95

3.64

mg/l

4.90

1293

7912

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1168

8432

1.36

21.40

1.7

1.6

3.70

3.84

mg/l

0.18

891

6053

Panic disorder

467

2926

1.64

21.25

1.6

4.09

4.08

mg/l

0.01

372

1950

Iron deficiency

128

522

2.64

21.05

1.7

1.6

4.00

2.82

mg/l

0.44

334

COPD

272

3993

0.55

20.90

1.7

1.6

10.31

3.41

mg/l

5.10

234

2900

Social phobias

292

1622

1.86

20.85

1.5

1.6

4.23

4.14

mg/l

0.04

229

1059

Pneumonias (Asthma/COPD co-morbidities)

1625

13935

0.78

20.76

1.9

1.6

6.07

3.49

mg/l

8.95

1333

9911

Hypothyroidism, strict autoimmune

1873

9733

1.28

20.65

1.8

1.6

4.08

3.69

mg/l

1.01

1487

6810

Pneumonia, organism unspecified

1376

12556

0.76

20.54

1.9

1.6

6.30

3.50

mg/l

8.37

1148

8952

COPD, early/later onset

257

3929

0.55

20.52

1.7

9.57

3.82

mg/l

4.05

221

2911

Allergic conjunctivitis

1500

11324

1.30

20.52

1.7

1.6

3.67

3.82

mg/l

0.26

1093

8132

All pneumoniae

1643

13986

0.78

20.51

1.9

1.6

6.12

3.49

mg/l

9.21

1349

9949

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

687

4191

1.49

20.30

1.5

3.85

3.92

mg/l

0.09

533

2712

COPD, hospital admissions

255

3898

0.55

20.15

1.7

9.64

3.83

mg/l

4.07

219

2887

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1445

10862

1.31

20.07

1.7

1.6

3.66

3.80

mg/l

0.23

1051

7790

Dipeptidyl peptidase 4 (DPP-4) inhibitors

461

5751

0.64

20.00

2.2

1.7

5.62

3.83

mg/l

2.21

402

4166

Cerebrovascular diseases

712

7172

0.69

19.94

1.7

3.83

3.87

mg/l

0.04

563

5303

Other chronic obstructive pulmonary disease

256

3795

0.55

19.83

1.7

1.6

9.61

3.42

mg/l

4.60

220

2759

Cardiomyopathy, other and unspecified

171

804

2.19

19.62

6.7

1.5

4.87

4.68

mg/l

0.06

155

567

Hypothyroidism, strict autoimmune, 3 medication purchases required

2000

10828

1.26

19.54

1.8

1.6

4.00

3.80

mg/l

0.42

1585

7694

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1985

0.34

19.35

1.5

1.7

8.49

3.88

mg/l

1.90

1457

Examination and observation for other reasons

1478

6599

1.31

19.24

1.8

1.6

3.96

3.70

mg/l

0.39

1149

4500

Bipolar affective disorders

527

3476

1.55

19.10

1.7

1.6

4.10

3.97

mg/l

0.11

442

2345

Other menopausal disorders

624

2362

1.51

18.70

1.6

1.7

2.81

4.04

mg/l

3.61

451

1760

Diarrhoea and gastroenteritis of presumed infectious origin

2406

13023

1.23

18.68

1.7

1.6

4.58

3.64

mg/l

3.39

1857

9233

Disorders of adult personality and behaviour

822

5924

1.41

18.67

1.6

3.75

3.86

mg/l

0.15

692

4135

Irritable bowel syndrome

685

4778

1.46

18.64

1.6

3.87

3.70

mg/l

0.17

535

3356

Personality disorders

775

5537

1.42

18.54

1.6

3.60

3.89

mg/l

0.55

655

3881

Peripheral artery disease

225

3276

0.54

18.46

1.6

1.7

5.65

4.03

mg/l

1.17

193

2433

Other medical care

386

5498

0.63

18.27

1.5

6.12

3.62

mg/l

2.39

300

3947

Female infertility

885

3885

1.40

18.26

1.5

1.6

4.00

4.08

mg/l

0.09

626

2731

Coxibs

619

2189

1.51

18.18

1.5

1.6

3.65

3.91

mg/l

0.33

474

1353

Eating disorder

332

1994

1.72

18.07

1.6

3.59

4.18

mg/l

0.63

253

1352

Female infertility, cervical, vaginal, other or unspecified origin

810

3768

1.42

18.04

1.5

1.6

3.94

4.09

mg/l

0.17

564

2654

Diseases of arteries, arterioles and capillaries

591

6344

0.68

18.00

1.8

1.7

4.44

3.94

mg/l

0.51

468

4668

Specific personality disorders

680

4781

1.45

17.87

1.6

3.75

3.92

mg/l

0.25

576

3337

Influenza and pneumonia

1806

14240

0.80

17.80

1.9

1.6

5.85

3.50

mg/l

8.71

1459

10079

COPD (mode)

189

2822

0.52

17.71

1.7

1.4

11.15

3.04

mg/l

4.57

161

1982

Post-traumatic stress disorder

291

1697

1.77

17.71

1.7

1.6

3.61

4.22

mg/l

0.58

235

1119

Use of hypnotics and sedatives

2477

11755

1.22

17.62

1.7

3.84

3.90

mg/l

0.11

1981

8452

Polyarthropathies

984

8580

0.74

17.61

2.0

1.6

5.10

3.74

mg/l

3.07

812

6047

Atherosclerosis, excluding cerebral and coronary sclerosis

188

2831

0.52

17.59

1.9

1.7

5.53

4.10

mg/l

0.78

158

2107

Other bacterial diseases

1364

11689

0.78

17.24

1.9

1.6

5.57

3.64

mg/l

5.43

1122

8438

Reimbursement for rheumatic diseases

699

9700

0.71

17.22

1.9

1.7

6.51

3.66

mg/l

4.52

572

7054

Malignant neoplasm of digestive organs

243

3362

0.56

17.20

1.4

1.7

4.51

3.90

mg/l

0.43

205

2474

Other bacterial diseases

1604

12727

0.79

17.06

1.8

1.6

5.62

3.63

mg/l

4.59

1298

9133

Oxycodone

305

4538

0.60

17.04

1.8

1.7

8.88

3.28

mg/l

4.67

266

3193

Genitourinary diseases

1475

5788

1.29

16.84

1.7

1.6

4.78

3.68

mg/l

1.32

1056

3962

General examination and investigation of persons without complaint and reported diagnosis

1603

6621

1.27

16.83

1.8

1.6

4.53

3.69

mg/l

1.63

1283

4509

Cardiomyopathy

310

1856

1.70

16.78

5.3

1.4

6.48

4.09

mg/l

2.16

282

1334

Deviated nasal septum

660

4654

1.43

16.77

1.6

1.7

3.87

3.91

mg/l

0.03

497

3358

Vasomotor and allergic rhinitis

992

7344

1.34

16.70

1.6

4.10

3.73

mg/l

0.63

729

5144

Endocrine, nutritional and metabolic diseases

2249

9363

1.23

16.64

1.8

1.5

4.63

3.39

mg/l

3.97

1857

6042

Cystitis

2017

9779

1.23

16.60

1.7

1.6

3.76

3.84

mg/l

0.13

1534

6986

Malignant neoplasm of bronchus and lung, including Hilmo

1562

0.37

16.58

2.4

1.6

4.66

3.89

mg/l

0.24

1142

Malignant neoplasm of respiratory system and intrathoracic organs

1515

0.36

16.55

2.1

1.6

5.09

3.79

mg/l

0.46

1104

Autoimmune diseases excluding thyroid diseases, strict definition

1742

11803

0.80

16.49

1.7

1.6

4.56

3.70

mg/l

2.34

1362

8179

Lung cancer and mesothelioma

1589

0.37

16.41

2.4

1.5

4.73

2.92

mg/l

0.76

1128

Later onset COPD

1350

0.35

16.04

1.3

1.5

9.39

3.37

mg/l

0.97

1019

Noninflammatory disorders of female genital tract

1125

4299

1.33

15.96

1.6

4.06

4.00

mg/l

0.04

806

3013

Extrapyramidal and movement disorders

628

4432

1.43

15.96

1.6

1.7

3.18

3.96

mg/l

1.74

509

3239

Neurological diseases

2280

9469

1.22

15.95

1.8

1.5

4.31

3.46

mg/l

2.01

1782

6338

Emotionally unstable personality disorder

400

2598

1.58

15.83

1.6

4.08

4.15

mg/l

0.06

339

1799

Autoimmune diseases excluding thyroid diseases

1800

12054

0.81

15.77

1.7

1.6

4.60

3.70

mg/l

2.65

1409

8375

Pain and other conditions associated with female genital organs and menstrual cycle

600

3875

1.45

15.70

1.6

3.33

4.03

mg/l

2.02

452

2718

AV-block

259

1313

1.75

15.55

7.6

1.5

3.34

4.08

mg/l

0.52

241

936

Liquid cancers, helper endpoint

292

4139

0.61

15.54

1.4

1.7

5.55

3.84

mg/l

1.53

228

2991

Sulfonylureas

154

2377

0.51

15.43

2.0

1.6

4.72

4.00

mg/l

0.30

134

1735

Any mental disorder

2584

10860

1.20

15.31

1.7

1.6

4.14

3.81

mg/l

0.78

2060

7438

COPD, hospital admission 2, with asthma infections

152

2522

0.51

15.24

1.7

10.49

3.85

mg/l

3.01

139

1873

Pain in throat and chest

2066

10247

1.22

15.07

1.9

1.6

4.51

3.54

mg/l

2.05

1617

7157

COPD, hospital admissions 1, only main diagnosis

168

2689

0.53

15.05

1.7

1.6

12.10

3.65

mg/l

4.24

148

1984

Bulimia nervosa (incl. atypical)

144

714

2.12

14.86

1.7

3.28

3.56

mg/l

0.26

113

477

COPD, hospital admissions 3, with asthma pneumonia sepsis

101

1902

0.45

14.82

1.7

1.6

12.07

3.67

mg/l

2.71

1417

Lyme disease

606

4316

1.42

14.78

1.6

1.7

3.20

3.92

mg/l

1.11

435

3167

Eating disorders

352

2255

1.60

14.77

1.6

3.47

4.10

mg/l

0.77

271

1549

COPD related to multimorbidity

211

3103

0.57

14.72

1.7

10.52

3.74

mg/l

4.06

186

2315

Malignant neoplasm of bronchus and lung

1270

0.34

14.70

2.3

1.6

3.64

3.73

mg/l

0.03

940

Bacterial pneumoniae

391

5179

0.66

14.56

2.0

1.6

7.31

3.58

mg/l

4.07

329

3688

Propionic acid derivatives

635

2252

1.43

14.45

1.7

1.6

3.69

3.92

mg/l

0.23

468

1384

Insulin medication

721

8190

0.73

14.43

1.9

1.6

5.45

3.74

mg/l

3.33

670

5727

Other spirochaetal diseases

610

4369

1.41

14.41

1.6

1.7

3.27

3.92

mg/l

0.95

438

3201

Fenamates

341

1455

1.61

14.38

1.5

1.7

3.33

3.70

mg/l

0.43

254

925

Spirochaetal infections, other/unspecified

608

4356

1.41

14.34

1.6

1.7

3.19

3.91

mg/l

1.12

437

3195

Bacterial pneumonia, not elsewhere classified

359

4815

0.65

14.31

1.9

1.6

7.37

3.56

mg/l

3.80

303

3432

Later onset COPD, excluding more controls

1225

0.36

14.28

1.3

1.4

9.56

2.80

mg/l

1.13

883

Acute upper respiratory infections

2380

12335

1.20

14.28

1.8

1.6

4.47

3.65

mg/l

3.09

1839

8724

Major coronary heart disease event excluding revascularizations

541

5106

0.70

14.27

2.2

1.5

5.03

3.45

mg/l

1.63

443

3739

Schizophrenia

140

2696

0.51

14.20

1.7

5.18

3.87

mg/l

1.02

121

1920

Pacemaker

371

2317

1.55

14.01

6.1

1.5

4.97

3.76

mg/l

1.20

337

1717

Other spirochaetal diseases

615

4438

1.40

13.92

1.6

1.7

3.25

3.91

mg/l

0.98

442

3251

Abnormalities of breathing

2221

10814

1.20

13.83

1.8

1.5

4.81

3.54

mg/l

5.60

1783

7504

Neurological diseases, wide definition

1010

3888

1.32

13.74

1.7

1.4

4.49

2.92

mg/l

2.22

790

2318

Chronic laryngitis and laryngotracheitis

283

1751

1.65

13.66

1.9

1.7

3.91

4.19

mg/l

0.18

207

1275

1502

11173

0.81

13.62

1.9

1.6

6.10

3.35

mg/l

9.09

1224

7810

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1502

11173

0.81

13.62

1.9

1.6

6.10

3.35

mg/l

9.09

1224

7810

Rheumatoid arthritis

312

4328

0.64

13.46

1.9

1.7

6.43

3.57

mg/l

2.60

249

3088

Biguanides

1500

11197

0.81

13.19

1.9

1.6

5.05

3.75

mg/l

5.18

1338

8034

Chronic periodontitis, complicated

604

8149

0.73

12.99

1.7

6.21

3.81

mg/l

1.94

518

5984

Antihypertensive medication - note that there are other indications

1901

8371

1.21

12.98

1.9

1.4

4.69

3.22

mg/l

4.29

1510

5390

Endometriosis

861

3834

1.33

12.96

1.5

1.6

3.36

4.01

mg/l

1.75

626

2715

Psychiatric diseases

2309

9769

1.19

12.82

1.7

1.6

3.99

3.86

mg/l

0.22

1798

6646

Myocardial infarction

402

4127

0.68

12.70

2.3

1.5

5.31

3.49

mg/l

1.42

333

3002

Second line medication for Crohn's disease

800

10420

0.76

12.68

3.4

1.6

6.94

3.70

mg/l

4.95

664

7532

Biological medication for rheuma

188

3204

0.58

12.54

1.5

1.7

6.44

4.00

mg/l

1.23

148

2285

Tonsillectomy and adenotomy

1641

9445

1.22

12.35

1.6

4.07

3.88

mg/l

0.36

1170

6671

STROKE

736

6592

0.75

12.27

1.8

1.5

4.05

3.46

mg/l

0.88

572

4774

Somatoform disorder

382

2592

1.50

12.27

1.7

4.22

4.01

mg/l

0.13

311

1834

Exposure to other specified factors

1753

13434

1.21

12.26

1.6

3.83

3.88

mg/l

0.08

1322

9558

Dermatitis and eczema

2549

13550

1.17

12.25

1.7

1.6

4.70

3.68

mg/l

2.82

1929

9648

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1091

4308

1.28

12.12

1.7

1.5

4.29

3.26

mg/l

1.08

816

2776

Acetic acid derivatives and related substances

576

2145

1.41

12.12

1.7

1.6

3.47

3.93

mg/l

0.46

433

1327

Gastro-oesophageal reflux disease

1403

9902

1.23

12.01

1.7

4.76

3.70

mg/l

1.47

1124

7180

Renal tubulo-interstitial diseases

1321

12052

0.81

11.99

2.0

1.6

5.68

3.71

mg/l

5.25

1074

8636

Migraine without aura

588

4331

1.38

11.93

1.7

1.6

3.85

3.76

mg/l

0.08

447

2924

Myocardial infarction, strict

364

3804

0.68

11.90

2.4

1.5

5.04

3.45

mg/l

1.16

299

2761

Anti-inflammatory and antirheumatic products, non-steroids

616

2252

1.39

11.87

1.7

1.6

3.55

3.92

mg/l

0.43

452

1384

Acute alcohol intoxication

239

3797

0.62

11.83

1.5

1.7

5.36

3.96

mg/l

1.01

208

2682

Intestinal infectious diseases

2626

12921

1.17

11.78

1.8

1.6

4.71

3.65

mg/l

2.83

2023

9165

Rheumatoid arthritis, including avohilmo

364

5303

0.68

11.78

1.8

1.7

6.39

3.70

mg/l

2.64

290

3899

Other eating disorders

180

1035

1.80

11.75

1.6

3.89

4.01

mg/l

0.08

143

687

Other (not insulin) diabetes medications

1591

11353

0.83

11.64

1.9

1.6

5.10

3.73

mg/l

6.41

1423

8072

Erysipelas

951

9170

0.79

11.48

1.8

1.6

5.75

3.57

mg/l

2.98

796

6660

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

203

3324

0.60

11.45

1.7

6.97

3.68

mg/l

1.82

163

2455

Other/unspecified seropositive rheumatoid arthritis

205

3343

0.61

11.36

1.7

7.21

3.68

mg/l

2.01

164

2468

764

8922

0.77

11.33

1.6

1.7

4.98

3.89

mg/l

1.96

654

6351

Transplanted organ and tissue status

208

1253

1.69

11.30

2.7

1.5

21.58

3.48

mg/l

10.94

195

895

Elevated blood glucose level

178

1029

1.77

11.27

2.2

1.7

5.28

4.32

mg/l

0.54

161

745

820

9244

0.78

11.25

1.6

1.7

5.07

3.88

mg/l

2.28

701

6577

Other reaction to severe stress, and adjustment disorders

949

7521

1.27

11.22

1.9

1.6

4.21

3.95

mg/l

0.30

780

5174

Allergic rhinitis

817

6289

1.30

11.16

1.6

4.04

3.78

mg/l

0.35

600

4407

Bacterial pneumonia (organism specified)

420

5364

0.70

11.15

2.0

1.7

7.62

3.65

mg/l

4.23

349

3848

L04AX Other immunosuppressants

780

10011

0.77

11.10

3.5

1.6

7.01

3.70

mg/l

4.93

647

7238

Bleeding

1066

9418

0.80

11.02

1.7

4.79

3.81

mg/l

1.03

843

6879

Malignant neoplasm

1394

9987

0.82

11.01

1.6

1.7

3.62

3.93

mg/l

0.64

1083

7334

Tumor necrosis factor alpha inhibitors

171

2880

0.58

10.97

1.5

1.7

6.72

3.99

mg/l

1.29

136

2041

Diseases of male genital organs

939

3711

1.29

10.88

1.6

1.7

3.94

3.99

mg/l

0.04

685

2609

Diseases of the eye and adnexa

2223

9518

1.18

10.87

1.7

1.6

3.99

3.80

mg/l

0.24

1644

6643

Caries of enamel

2137

13202

1.17

10.83

1.8

1.6

4.35

3.77

mg/l

0.98

1542

9491

Other headache syndromes

957

7633

1.26

10.59

1.7

1.6

3.46

3.59

mg/l

0.19

745

5274

Functional dyspepsia

552

4100

1.36

10.57

1.8

1.7

5.39

3.63

mg/l

1.62

428

2964

Organic, including symptomatic, mental disorders

328

3402

0.68

10.36

1.6

1.7

4.11

3.90

mg/l

0.12

265

2525

Diabetes medication

1849

12879

0.85

10.35

1.9

1.6

5.00

3.66

mg/l

7.18

1667

9011

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2569

12128

1.16

10.29

1.7

1.6

4.39

3.70

mg/l

1.50

1993

8543

Insulin, combination of fast acting with intermediate-acting or long-acting

721

8467

0.77

10.27

1.9

1.7

5.45

3.84

mg/l

3.03

670

6071

Any dementia

143

1740

0.57

10.21

1.5

1.6

3.95

3.40

mg/l

0.20

107

1307

Acute alcohol intoxication, ICD10

201

3202

0.62

10.20

1.5

1.7

4.72

4.14

mg/l

0.37

172

2295

Any dementia, excluding more controls

139

1686

0.56

10.15

1.5

1.6

4.05

3.62

mg/l

0.14

104

1231

Any event in cancer register

1656

11530

0.84

10.07

1.6

1.7

3.63

3.98

mg/l

0.80

1261

8366

Migraine without aura and triptan purchases

483

3553

1.38

10.03

1.8

1.6

3.48

4.05

mg/l

0.73

363

2498

Seropositive rheumatoid arthritis, wide

217

3387

0.63

10.00

2.0

1.7

6.98

3.68

mg/l

1.99

175

2499

Status post-ami

126

1724

0.55

9.96

2.0

1.5

6.51

3.49

mg/l

0.80

102

1255

Other disorders of breast

305

2073

1.50

9.88

1.5

1.7

3.17

3.95

mg/l

1.00

211

1508

Cerebrovascular diseases (FINNGEN)

439

4261

0.72

9.88

1.8

1.4

4.20

3.31

mg/l

0.98

342

2949

Diseases of pulp and periapical tissues, including avohilmo

1970

11893

0.85

9.83

1.7

1.6

4.58

3.59

mg/l

2.22

1559

8242

Non-small cell lung cancer, including Hilmo

1163

0.41

9.77

2.4

1.6

4.97

3.74

mg/l

0.32

859

Hypertrophy of breast

431

3129

1.40

9.70

1.6

1.7

3.54

3.87

mg/l

0.43

365

2285

Dentofacial anomalies [including malocclusion]

1766

12093

1.18

9.69

1.6

3.41

3.93

mg/l

2.03

1250

8677

Asthma, including avohilmo

2718

13385

1.15

9.59

1.6

4.93

3.60

mg/l

4.81

2093

9472

Disturbances of skin sensation

652

5035

1.31

9.59

1.7

3.80

3.95

mg/l

0.12

513

3636

Other specific joint derangements/joint disorders

1884

10418

1.18

9.58

1.7

1.6

4.48

3.67

mg/l

2.10

1471

7173

Use of pramipexole

353

2476

1.44

9.57

1.7

1.6

3.63

3.80

mg/l

0.14

304

1836

Seropositive rheumatoid arthritis

217

3339

0.64

9.55

2.0

1.7

6.98

3.40

mg/l

2.27

175

2341

Exposure to unspecified factor

2248

14042

1.16

9.54

1.6

3.93

3.83

mg/l

0.17

1720

10000

Acute upper respiratory infections of multiple and unspecified sites

1779

11251

1.18

9.53

1.7

1.6

5.03

3.69

mg/l

4.59

1354

7881

Mental and behavioural disorders due to alcohol

677

8333

0.78

9.48

1.6

1.7

4.85

3.88

mg/l

1.54

583

5925

Autism spe, excluding more controls

365

2.23

9.44

1.5

1.7

3.16

3.12

mg/l

0.03

217

Other degenerative diseases of the nervous system

230

2627

0.65

9.44

1.6

4.12

3.59

mg/l

0.36

168

1804

Anaemias

665

3344

1.31

9.41

1.9

1.3

5.85

3.18

mg/l

4.36

535

2017

Solid cancers, helper endpoint

1398

9835

0.83

9.35

1.6

1.7

3.52

3.93

mg/l

0.93

1089

7230

Bacterial infection, other or unspecified

636

6933

0.77

9.30

1.8

1.6

6.12

3.61

mg/l

4.09

517

5010

Alcohol dependence

261

3851

0.67

9.20

1.6

1.7

5.00

3.98

mg/l

0.72

239

2754

Dementia, including avohilmo

220

2327

0.65

9.18

1.5

1.6

3.65

3.64

mg/l

0.00

169

1730

Symptoms and signs involving the skin and subcutaneous tissue

1468

12141

1.19

9.16

1.7

1.6

4.45

3.80

mg/l

1.14

1118

8803

Type 2 diabetes, wide definition

1096

8512

0.82

9.02

2.1

1.6

5.04

3.71

mg/l

3.57

1001

6092

Conduction disorders

457

2728

1.37

9.02

5.5

1.4

3.70

3.80

mg/l

0.08

399

1955

Caries of dentine, including avohilmo

1390

8452

0.84

9.00

1.8

1.6

4.61

3.36

mg/l

1.88

1058

5887

Malignant neoplasm, wide definition for exclusion

1510

10443

0.84

8.97

1.6

1.7

3.73

3.95

mg/l

0.39

1170

7641

GASTRO-related operations

2108

9145

1.16

8.94

1.8

1.5

5.01

3.23

mg/l

5.53

1627

6096

Any gastric operation

2108

9145

1.16

8.94

1.8

1.5

5.01

3.23

mg/l

5.53

1627

6096

Psychotic depression

146

856

1.74

8.91

1.7

3.01

3.64

mg/l

0.65

127

560

Fentanyl

966

0.37

8.88

1.6

1.7

6.11

3.13

mg/l

1.11

688

Hypertrophy of breast in women and men

464

3459

1.36

8.84

1.7

3.40

3.90

mg/l

0.80

393

2529

Dislocation, sprain and strain of joints and ligaments of knee

1467

11465

1.19

8.79

1.6

3.96

3.85

mg/l

0.17

1100

8160

Codeine or tramadol medication

2631

12671

1.14

8.79

1.7

1.6

4.43

3.72

mg/l

2.38

2139

8855

Persons encountering health services for examination and investigation

1561

6621

1.19

8.77

1.7

1.6

4.47

3.69

mg/l

1.48

1170

4509

Methotrexate

117

2049

0.56

8.77

1.6

1.5

5.83

3.61

mg/l

0.95

1484

Chronic apical periodontitis

2078

13603

0.87

8.76

1.7

1.6

4.70

3.69

mg/l

2.44

1671

9618

Pollen allergy

513

3838

1.34

8.75

1.6

3.86

4.06

mg/l

0.22

375

2659

Diseases of arteries, arterioles and capillaries (FINNGEN)

281

2814

0.68

8.72

1.8

1.4

5.46

3.16

mg/l

2.02

224

1915

Seropositive rheumatoid arthritis, strict definition

115

2015

0.56

8.65

1.5

1.6

7.70

3.68

mg/l

1.46

1493

Bacterial infection, other or unspecified

563

6326

0.77

8.58

1.9

1.6

6.38

3.60

mg/l

4.12

465

4570

Cholecystectomy

1351

9826

1.19

8.56

1.8

1.7

5.00

3.76

mg/l

2.17

1148

7204

Coronary atherosclerosis

713

5685

0.79

8.43

1.9

1.5

5.41

3.47

mg/l

2.33

571

4158

Cough

801

6088

1.25

8.43

1.9

1.6

4.44

3.57

mg/l

1.19

600

4327

Subjective visual disturbances

497

3767

1.33

8.43

1.9

1.7

3.76

3.87

mg/l

0.09

386

2731

Psoriasis

309

4347

0.70

8.42

1.8

1.7

4.47

3.86

mg/l

0.52

256

3152

Adenomyosis (Endometriosis of uterus)

255

1728

1.50

8.40

1.5

1.7

3.54

3.90

mg/l

0.27

197

1265

Atopic dermatitis

1528

10689

1.18

8.38

1.6

4.31

3.70

mg/l

1.34

1119

7559

Thyroiditis, ILD-related definition

278

1926

1.47

8.25

1.8

1.7

3.95

3.80

mg/l

0.10

221

1390

Paracetamol or NSAID medication

427

1571

1.38

8.23

1.8

1.5

3.69

3.71

mg/l

0.01

306

904

Peripheral arterial reconstruction

1105

0.43

8.21

1.9

1.6

8.17

3.79

mg/l

0.83

834

Non-rheumatic valve diseases

477

4526

0.76

8.08

2.1

1.4

4.33

3.90

mg/l

0.32

345

3242

Asthma (mode)

1865

8638

1.16

8.07

1.7

1.4

4.95

3.18

mg/l

5.28

1462

5941

Sulfasalazine

350

4790

0.72

8.06

1.6

1.5

4.76

3.46

mg/l

2.22

280

3408

Oter anti-inflammatory and antirheumatic agents, non-steroids

321

1240

1.44

8.03

1.7

1.8

3.62

4.10

mg/l

0.36

258

842

L04AD Calcineurin inhibitors

234

1577

1.51

8.00

4.5

1.7

18.97

3.64

mg/l

9.93

220

1132

Unspecified/other endometriosis

263

1816

1.48

8.00

1.6

3.64

4.02

mg/l

0.47

189

1261

Disorders of lacrimal system

791

6376

1.25

7.99

1.9

1.7

3.94

3.85

mg/l

0.08

625

4671

Other or ill-defined heart diseases

116

658

1.80

7.98

8.8

1.4

2.41

4.73

mg/l

1.63

110

466

Alcohol use disorder, Swedish definition

733

8345

0.80

7.94

1.6

1.7

5.19

3.90

mg/l

2.22

631

5988

Fracture of femur

134

2008

0.60

7.92

1.6

3.24

3.77

mg/l

0.44

115

1490

Excessive, frequent and irregular menstruation

946

4238

1.23

7.89

1.6

4.49

4.01

mg/l

0.36

731

2980

Dementia

206

2137

0.66

7.87

1.5

1.6

3.71

3.63

mg/l

0.03

157

1588

Myalgia

541

4191

1.30

7.87

1.8

1.6

3.82

3.94

mg/l

0.11

430

2920

Other heart diseases, wide

2213

11889

1.14

7.84

2.7

1.4

4.14

3.79

mg/l

0.76

1746

8450

Valvular heart disease excluding rheumatic fever

483

4554

0.76

7.78

2.1

1.4

4.33

3.88

mg/l

0.33

351

3264

Persons encountering health services in other circumstances, wide

2655

12131

1.13

7.76

1.8

1.6

4.43

3.70

mg/l

1.71

2063

8546

Personal history of malignant neoplasm

150

922

1.66

7.74

1.8

1.5

2.69

3.95

mg/l

1.07

124

684

Other disorders of lacrimal gland

659

5245

1.27

7.67

2.0

1.6

4.08

3.86

mg/l

0.20

522

3842

Other arrhythmias

1395

8983

1.18

7.60

2.4

1.4

3.75

3.81

mg/l

0.07

1068

6452

Ischaemic heart disease, wide definition

975

7279

0.83

7.55

2.1

1.6

5.33

3.83

mg/l

2.01

786

5398

Polyuria

340

2478

1.38

7.49

1.7

4.42

3.86

mg/l

0.28

252

1807

Tinnitus

430

3251

1.34

7.48

1.5

1.7

3.74

3.85

mg/l

0.06

307

2387

Dental caries, including avohilmo

1289

7758

0.85

7.39

1.7

1.6

4.43

3.37

mg/l

1.38

977

5425

Diaphragmatic hernia

550

4302

1.29

7.38

1.7

5.00

3.51

mg/l

1.63

447

3169

Monoamine oxidase A inhibitors

214

1440

1.51

7.37

1.7

2.90

4.02

mg/l

1.26

173

992

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1687

0.56

7.35

1.4

1.7

5.14

3.90

mg/l

0.58

1231

Cardiac arrhythmias

1584

8891

1.16

7.30

2.7

1.4

4.10

3.40

mg/l

1.73

1230

6084

Diseases of pulp and periapical tissues and dental caries

1164

7064

0.84

7.26

1.8

1.6

4.76

3.31

mg/l

1.89

888

4895

Disorders of breast

1108

8479

1.19

7.25

1.6

3.46

3.84

mg/l

0.86

844

6189

Schizophrenia or delusion

442

5750

0.76

7.22

1.6

1.7

4.39

3.88

mg/l

0.73

369

4086

Alcohol abuse, main dg

159

2454

0.64

7.18

1.6

1.7

4.50

4.29

mg/l

0.10

140

1758

Endometriosis of pelvic peritoneum

397

2848

1.35

7.16

1.6

1.7

3.66

4.16

mg/l

0.88

295

2032

Codeine

2321

11174

1.13

7.12

1.7

1.6

4.44

3.46

mg/l

3.76

1890

7656

Non-small cell lung cancer

723

0.35

7.11

2.0

1.7

4.32

3.74

mg/l

0.13

538

Injuries to the knee and lower leg

2694

13367

1.12

7.10

1.6

4.06

3.81

mg/l

0.66

2048

9493

Coronary artery bypass grafting

132

1590

0.61

7.09

1.5

3.07

3.56

mg/l

0.32

104

1156

Obsessive-compulsive disorder

191

1271

1.53

7.06

1.6

2.93

4.40

mg/l

1.56

156

820

Allergic asthma (mode), excluding more controls

615

4804

1.26

7.05

1.6

1.4

4.21

3.11

mg/l

2.48

459

3172

Allergic asthma (mode)

615

4805

1.26

7.04

1.6

1.4

4.21

3.15

mg/l

2.32

459

3188

Spirochaetal infections, other/unspecified

160

1023

1.59

7.03

1.9

1.7

3.74

4.28

mg/l

0.22

113

756

Angina pectoris

572

4813

0.79

7.01

2.0

1.5

4.97

3.42

mg/l

1.44

456

3502

Other (seronegative) rheumatoid arthritis, wide

152

2358

0.64

7.00

1.6

1.7

7.49

3.62

mg/l

1.54

118

1740

Schizophrenia, schizotypal and delusional disorders

445

5759

0.77

7.00

1.6

1.7

4.38

3.88

mg/l

0.71

370

4094

Asthma and allergy, excluding more controls

366

2702

1.35

6.94

1.5

1.4

4.06

3.28

mg/l

0.94

265

1762

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1051

8849

1.19

6.93

1.8

1.7

4.65

3.83

mg/l

1.58

850

6454

Endometriosis of ovary

373

2729

1.35

6.92

1.6

1.7

3.60

4.05

mg/l

0.45

257

1963

Soft tissue disorders

2454

11248

1.13

6.90

1.6

3.76

3.82

mg/l

0.11

1919

7746

Periapical abscess

629

7804

0.80

6.89

1.6

1.7

4.58

3.99

mg/l

0.60

500

5690

All-cause Heart Failure

464

4230

0.77

6.89

3.4

1.6

6.43

3.60

mg/l

3.82

434

3096

Asthma and allergy

366

2705

1.35

6.89

1.5

1.4

4.06

3.31

mg/l

0.89

265

1765

Cardiovascular diseases

1858

8747

1.15

6.88

2.0

1.4

4.50

3.41

mg/l

2.30

1410

5809

Follow-up examination after treatment for conditions other than malignant neoplasms

1015

5625

1.20

6.87

1.6

3.32

3.69

mg/l

0.86

778

3857

All chronic kidney diseases

604

6165

0.80

6.85

2.1

1.6

6.30

3.64

mg/l

4.11

521

4430

Migraine with aura

629

5057

1.26

6.81

1.7

1.6

3.70

3.68

mg/l

0.02

477

3411

Asthma (only as main-diagnosis)

1703

8594

1.15

6.78

1.7

1.4

5.02

3.17

mg/l

8.01

1314

5903

Hypogonadotropic hypogonadism

387

1.98

6.74

1.4

1.8

4.33

4.57

mg/l

0.08

281

Enthesopathies of lower limb, excluding foot

476

3707

1.30

6.73

1.7

3.54

3.96

mg/l

0.53

372

2657

Asthma (only as main-diagnosis), excluding more controls

1690

8430

1.15

6.67

1.7

1.4

5.02

3.13

mg/l

8.23

1305

5752

Other diseases of pleura

358

4163

0.75

6.66

2.1

1.7

12.23

3.68

mg/l

7.56

301

3071

Agoraphobia

101

585

1.78

6.65

1.5

1.7

4.08

3.63

mg/l

0.28

368

Mouth breathing

743

6086

1.23

6.63

1.7

3.63

3.98

mg/l

0.51

589

4441

Asthma, excluding more controls

1843

8430

1.15

6.63

1.7

1.4

5.36

3.13

mg/l

7.01

1450

5752

ILD medications: immunosuppressive drugs

1036

11348

0.84

6.61

3.3

1.4

8.39

3.32

mg/l

12.38

871

7966

Etanercept

1059

0.48

6.60

1.4

1.7

5.13

4.29

mg/l

0.34

766

Abnormal results of function studies

177

1175

1.53

6.60

2.0

1.7

3.09

3.96

mg/l

0.73

141

859

Cardiomyopathies, Primary/intrinsic

180

1197

1.52

6.59

4.7

1.4

8.19

4.34

mg/l

2.41

163

856

Inflammatory diseases of prostate (prostatitis)

179

1189

1.52

6.58

1.5

1.8

2.81

3.95

mg/l

1.03

127

851

Other disorders of veins

750

6126

1.23

6.57

1.7

3.42

3.84

mg/l

0.72

583

4550

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

689

5593

1.24

6.57

1.6

4.42

3.80

mg/l

1.18

576

3689

Asthma

1866

8594

1.14

6.56

1.7

1.4

5.33

3.17

mg/l

6.79

1469

5903

Other and unspecified mood [affective] disorders

195

1326

1.50

6.52

1.6

4.38

4.35

mg/l

0.01

153

874

Insulin, intermediate and long-acting

653

7790

0.81

6.47

1.8

1.7

4.97

3.88

mg/l

1.82

605

5600

Excessive earwax

893

7285

1.20

6.47

1.7

4.53

3.80

mg/l

0.71

672

5291

Pain (limb, back, neck, head abdominally)

1703

7452

1.15

6.46

1.7

1.6

4.50

3.49

mg/l

1.77

1288

5045

Wide developmental disorders, excluding more controls

471

1.85

6.44

1.5

1.6

3.01

3.65

mg/l

0.46

286

Infections with a predominantly sexual mode of transmission

813

6746

1.21

6.43

1.6

3.48

3.87

mg/l

0.58

620

4724

Adalimumab

104

1718

0.60

6.43

1.7

6.91

4.14

mg/l

1.12

1242

Inflammatory bowel disease, strict (require KELA)

315

4217

0.74

6.42

1.5

1.7

3.88

3.96

mg/l

0.07

236

3014

All kidney diseases

1759

13635

0.88

6.38

1.9

1.6

5.13

3.69

mg/l

4.58

1420

9738

Retinal breaks without detachment

270

1952

1.40

6.37

1.9

1.7

3.40

3.97

mg/l

0.56

198

1452

Procreative management

797

5507

1.22

6.32

1.6

4.57

3.91

mg/l

0.65

541

3981

Mental and behavioural disorders due to alcohol, excluding acute intoxication

578

7126

0.80

6.28

1.6

1.7

4.96

3.94

mg/l

1.37

503

5135

Inflammatory diseases of female pelvic organs

1470

9417

1.15

6.20

1.6

3.66

3.79

mg/l

0.27

1132

6752

IBD patients in KELA-register

315

4191

0.74

6.17

1.5

1.7

3.88

3.94

mg/l

0.05

236

2977

Mixed and other personality disorders

211

1474

1.46

6.17

1.6

1.7

3.72

4.15

mg/l

0.32

181

1044

Failed induction of labour

199

1378

1.48

6.17

1.7

3.42

4.64

mg/l

1.42

166

957

Seborrhoeic keratosis

313

2329

1.35

6.14

1.5

1.7

4.80

3.84

mg/l

0.41

226

1736

Amiodarone users

128

802

1.62

6.14

8.1

1.5

6.70

4.31

mg/l

0.86

120

593

Other diseases of intestines

2494

12743

1.12

6.13

1.7

1.6

4.52

3.75

mg/l

1.80

1944

8979

Type 2 diabetes, strict (exclude DM1)

1651

11023

0.88

6.13

2.2

1.6

5.11

3.71

mg/l

6.33

1472

7806

Unstable angina pectoris

264

2851

0.73

6.08

1.9

1.5

3.94

3.34

mg/l

0.31

208

2071

Other disorders starting during childhood or adolecense, excluding more controls

121

719

1.64

6.07

1.4

1.6

4.32

3.28

mg/l

0.89

427

Sequelae of cerebrovascular disease

248

2951

0.72

6.04

1.7

3.50

3.96

mg/l

0.28

187

2181

Haemorrhoids and perianal venous thrombosis

515

4096

1.26

6.00

1.6

1.7

3.92

3.72

mg/l

0.12

397

2928

Invasive ventilation

823

0.44

6.00

2.3

1.6

6.58

4.26

mg/l

0.40

596

Infections with a predominantly sexual mode of transmission

1073

8557

1.18

5.98

1.6

3.63

3.86

mg/l

0.32

792

5933

malignant neoplasm of female genital organs

104

1680

0.61

5.96

1.5

1.6

5.85

3.71

mg/l

0.78

1243

Visual disturbances

892

7523

1.19

5.95

1.8

1.6

3.66

3.81

mg/l

0.20

684

5402

Gastrointestinal diseases

1637

7192

1.15

5.94

1.7

1.6

4.50

3.42

mg/l

1.92

1258

4771

Polyp of the female genital tract

623

2895

1.25

5.94

1.9

1.7

4.12

3.99

mg/l

0.11

477

2111

Other disorders of fluid, electrolyte and acid-base balance

252

3287

0.73

5.93

2.3

1.6

4.68

3.79

mg/l

0.59

207

2376

Postviral fatigue syndrome

163

2.51

5.92

2.0

1.8

3.46

3.00

mg/l

0.20

109

Persons encountering health services in circumstances related to reproduction

1363

7986

1.16

5.85

1.6

1.7

4.24

3.92

mg/l

0.41

964

5815

Anxious personality disorder

365

1.94

5.85

1.5

1.9

3.02

3.45

mg/l

0.30

251

Other heart diseases

1246

7032

1.16

5.83

3.5

1.4

4.49

3.37

mg/l

2.91

1000

4812

Primary_lymphoid and hematopoietic malignant neoplasms

167

2444

0.68

5.82

1.4

1.7

4.48

3.90

mg/l

0.38

127

1803

Type 2 diabetes, definitions combined

1654

11000

0.88

5.81

2.2

1.6

5.13

3.69

mg/l

6.64

1475

7784

Hypertensive heart and/or renal disease

186

2000

0.69

5.81

1.7

1.6

3.98

3.60

mg/l

0.16

161

1416

Other and unspecified disorders of skin and subcutaneous tissue

121

761

1.62

5.79

1.5

1.8

5.76

4.13

mg/l

0.49

556

Arthropod-borne viral fevers and viral haemorrhagic fevers

1221

0.55

5.77

1.2

1.7

4.50

4.36

mg/l

0.03

905

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1129

9601

1.17

5.77

1.8

1.7

4.68

3.83

mg/l

1.75

914

6985

Operations 2 for CAVS

130

1936

0.65

5.74

1.6

3.72

3.92

mg/l

0.14

103

1440

Calcific aortic valvular stenosis, diagnosis (helper)

130

1936

0.65

5.74

1.6

3.72

3.92

mg/l

0.14

103

1440

Bacterial Sepsis

446

4815

0.79

5.73

2.1

1.6

8.81

3.55

mg/l

5.98

384

3484

Certain infectious and parasitic diseases

1800

7973

1.14

5.73

1.8

1.6

4.34

3.48

mg/l

1.49

1342

5520

Autism

454

1.82

5.72

1.5

1.7

3.10

3.97

mg/l

0.75

300

Seronegative rheumatoid arthritis

1547

0.60

5.72

1.7

1.6

5.64

3.64

mg/l

0.89

1084

Other neurological diseases

897

8316

0.84

5.72

1.8

1.7

4.21

3.84

mg/l

0.43

689

6108

Diseases of the ear and mastoid process

2764

12571

1.11

5.71

1.6

3.97

3.82

mg/l

0.29

2035

8998

Calcific aortic valvular stenosis, including rheumatic fever

131

1942

0.65

5.69

1.5

1.6

3.68

3.92

mg/l

0.17

104

1445

Melanocytic naevi

608

4973

1.23

5.68

1.6

1.7

3.99

3.97

mg/l

0.01

423

3608

Calcific aortic valvular stenosis, operated

131

1942

0.65

5.67

1.5

1.6

3.69

3.92

mg/l

0.16

104

1443

Calcific aortic valvular stenosis

131

1942

0.65

5.67

1.5

1.6

3.69

3.92

mg/l

0.16

104

1443

Autism spe

441

1.83

5.66

1.5

1.7

3.16

4.02

mg/l

0.70

290

Psoriasis vulgaris

191

2706

0.70

5.62

1.6

1.7

5.57

3.99

mg/l

1.04

154

1964

Cardiomyopathy (excluding other)

183

1266

1.46

5.57

4.6

1.4

8.16

4.23

mg/l

2.60

166

915

Diseases of oesophagus, stomach and duodenum

2312

12447

1.11

5.56

1.7

1.6

4.70

3.70

mg/l

2.32

1843

8903

Dementia in Alzheimer disease

607

0.43

5.50

1.4

1.5

4.23

2.99

mg/l

0.37

478

Visual disturbances and blindness

934

7963

1.18

5.48

1.8

1.6

3.76

3.79

mg/l

0.04

720

5724

Irregular menses

1270

8744

1.15

5.47

1.7

1.6

4.33

3.71

mg/l

0.77

990

6224

Presbyopia

145

966

1.53

5.43

1.8

1.7

4.69

4.31

mg/l

0.08

107

728

Candidiasis

582

4764

1.23

5.42

1.8

1.6

4.87

3.83

mg/l

1.17

433

3417

Anankastic personality disorder

112

707

1.63

5.40

1.4

1.7

2.90

4.33

mg/l

0.81

497

Disorders of refraction and accommodation

591

4830

1.23

5.39

1.6

3.97

3.93

mg/l

0.03

440

3434

Type 2 diabetes, definitions combined, including avohilmo

1691

11082

0.89

5.37

2.1

1.6

5.13

3.68

mg/l

6.81

1503

7818

Menorrhagia

736

3398

1.21

5.34

1.7

1.6

3.19

4.06

mg/l

2.53

556

2436

Dilated cardiomyopathy

161

1098

1.48

5.31

4.6

1.7

8.26

4.08

mg/l

2.53

146

805

Ovarian cyst

826

4012

1.20

5.29

1.5

1.6

3.93

4.04

mg/l

0.13

615

2829

Arthropathic psoriasis

105

1648

0.63

5.27

1.5

1.7

4.22

4.02

mg/l

0.11

1214

Acute sinusitis

1225

9901

1.15

5.26

1.8

1.6

4.34

3.67

mg/l

1.43

974

6942

Mental and behavioural disorders due to psychoactive substance use

911

9855

0.85

5.24

1.6

4.83

3.88

mg/l

1.92

787

6986

Oxicams

378

1662

1.30

5.21

1.7

4.30

4.04

mg/l

0.13

293

1075

Senile cataract

734

5362

0.83

5.21

1.8

1.7

4.19

3.74

mg/l

0.52

573

4000

Convalescence

116

743

1.59

5.21

1.4

1.5

2.80

3.91

mg/l

0.66

530

Unspecified dementia

408

0.31

5.20

1.1

1.6

2.91

3.07

mg/l

—

338

Temporomandibular joint disorders, including avohilmo

1100

9414

1.16

5.19

1.7

1.6

3.34

3.89

mg/l

1.79

785

6689

Ascites

764

0.47

5.18

1.5

1.6

6.51

3.54

mg/l

1.15

566

Other Crohn's disease

1179

0.57

5.18

1.3

1.7

4.50

4.41

mg/l

0.03

831

Other soft tissue disorders, not elsewhere classified

2108

11116

1.12

5.17

1.8

1.6

3.99

3.83

mg/l

0.31

1687

7676

Pleural effusion

1245

0.58

5.12

2.4

1.6

9.04

3.35

mg/l

1.46

906

Heart failure, strict

497

4323

0.81

5.09

3.6

1.6

6.61

3.60

mg/l

4.56

464

3161

Psoriatic and enteropathic arthropathies

123

1851

0.66

5.08

1.8

1.7

3.70

3.80

mg/l

0.07

105

1292

Other specified and unspecified personality disorders

221

1615

1.39

5.05

1.8

1.7

4.39

4.28

mg/l

0.06

198

1155

Spondylopathies

1216

8311

0.87

5.05

1.7

4.20

3.85

mg/l

0.44

962

6018

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

419

3342

1.27

5.05

1.8

1.6

3.96

3.92

mg/l

0.03

312

2354

Undefined dementia

411

0.31

5.05

1.1

1.6

2.91

3.08

mg/l

—

339

Papulosquamous disorders

485

5962

0.81

5.01

1.8

1.7

5.08

3.78

mg/l

1.54

394

4356

malignant neoplasm of male genital organs

234

1931

0.73

5.00

1.5

1.7

3.67

4.22

mg/l

0.29

176

1397

Alcohol use disorder, ICD-based

545

6619

0.82

4.99

1.6

1.7

4.82

4.00

mg/l

0.97

475

4779

Type 2 diabetes

1805

11767

0.89

4.98

2.1

1.6

5.11

3.66

mg/l

7.42

1621

8265

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1554

0.63

4.96

1.6

1.7

5.58

4.20

mg/l

0.99

1144

Early onset COPD

198

2726

0.72

4.94

1.8

1.7

9.63

3.80

mg/l

3.72

170

2013

Malignant neoplasm of pancreas, including Hilmo

696

0.45

4.93

1.5

1.7

5.83

4.24

mg/l

0.27

506

307

2364

1.31

4.90

2.5

1.6

4.98

3.85

mg/l

0.94

243

1665

Retinal detachments and breaks

496

4039

1.23

4.87

1.9

1.7

3.70

4.08

mg/l

0.36

373

2990

Ulcerative colitis, NAS

156

2225

0.69

4.86

1.7

3.56

4.00

mg/l

0.41

123

1594

Diabetes, varying definitions

1941

12628

0.90

4.85

2.1

1.6

4.99

3.63

mg/l

7.32

1747

8797

Other condition

155

2212

0.69

4.85

1.6

1.7

5.77

4.11

mg/l

0.77

112

1588

Desensitization to allergens

156

1083

1.47

4.84

1.3

1.7

3.69

4.78

mg/l

0.68

105

740

Adenocarcinoma and ductal carcinoma of pancreas

290

0.27

4.84

1.0

1.7

6.79

5.32

mg/l

—

216

Heart failure,strict

490

4243

0.81

4.83

3.6

1.6

6.58

3.49

mg/l

4.85

458

3072

Secondary uncertain malignant neoplasm

1271

0.60

4.79

1.4

1.7

7.26

4.05

mg/l

0.59

920

Other problems related to primary support group, including family circumstances

286

2130

1.32

4.79

1.8

1.6

4.69

4.16

mg/l

0.40

238

1500

Focal epilepsy, mode (most common among epilepsy diagnosis)

182

2522

0.72

4.77

1.6

1.7

5.17

3.94

mg/l

0.53

138

1812

Implicit Sepsis

1067

9229

0.87

4.76

2.2

1.6

6.70

3.58

mg/l

7.98

889

6641

Excluding asthma or asthma-COPD overlap

1926

8671

1.12

4.75

2.0

1.4

4.84

3.18

mg/l

4.38

1488

5954

ILD differential diagnosis

1919

8638

1.12

4.75

2.0

1.4

4.85

3.18

mg/l

4.40

1479

5941

Oligomenorrhoea

580

1.64

4.74

2.1

1.7

3.78

3.68

mg/l

0.06

398

Diabetes mellitus

1959

12678

0.90

4.70

2.1

1.6

4.96

3.63

mg/l

7.12

1765

8822

Focal epilepsy

217

2918

0.74

4.69

1.5

1.7

6.11

3.92

mg/l

0.99

168

2107

Gestational diabetes (for exclusion)

1102

6693

1.15

4.69

1.7

1.6

4.10

3.88

mg/l

0.41

885

4664

Unspecified urinary incontinence

141

963

1.48

4.69

1.5

1.7

4.17

3.74

mg/l

0.23

114

718

COPD differential diagnosis

1918

8641

1.12

4.68

2.0

1.4

4.85

3.18

mg/l

4.37

1478

5942

Psoriatic arthropathies, ICD10

1529

0.64

4.68

1.5

1.7

3.92

4.25

mg/l

0.20

1130

Degenerative diseases of the nervous system

146

1547

0.69

4.66

1.5

1.6

3.55

3.68

mg/l

0.06

113

1176

General symptoms and signs

2552

11666

1.10

4.66

1.9

1.5

4.39

3.62

mg/l

2.76

1994

8112

Colorectal cancer

158

2183

0.70

4.62

1.3

1.6

3.67

3.78

mg/l

0.07

133

1599

Factors influencing health status and contact with health services

690

2902

1.20

4.59

1.8

1.4

5.31

3.31

mg/l

1.36

498

1956

Asthma, hospital admissions , main diagnosis only

1741

13813

1.12

4.59

1.7

1.6

4.98

3.69

mg/l

4.32

1341

9854

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1040

0.57

4.59

1.2

1.7

4.56

4.34

mg/l

0.04

763

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1164

0.59

4.59

1.3

1.7

3.89

4.43

mg/l

0.29

821

Septicaemia

417

4823

0.80

4.57

2.1

1.6

6.70

3.66

mg/l

3.08

357

3468

Psoriatic arthropathies

100

1533

0.64

4.57

1.5

1.6

3.92

3.81

mg/l

0.06

1064

Crohn disease (strict definition, require KELA)

1096

0.58

4.51

1.3

1.7

4.02

4.52

mg/l

0.25

770

Erysipelas

685

7144

0.84

4.50

1.9

1.6

5.46

3.60

mg/l

2.97

585

5195

Testicular dysfunction

449

1.71

4.48

2.0

1.8

4.40

4.98

mg/l

0.10

332

Sensorineural hearing loss

957

7479

0.87

4.48

1.6

1.7

4.28

3.90

mg/l

0.38

708

5571

Explicit Sepsis

476

5409

0.82

4.48

2.0

1.6

6.43

3.65

mg/l

3.17

399

3877

L04AC Interleukin inhibitors

979

0.56

4.47

1.4

1.8

6.21

4.51

mg/l

0.49

701

Alcohol abuse, main dg, excluding more controls

159

2226

0.71

4.47

1.6

1.7

4.50

3.93

mg/l

0.29

140

1510

Diseases of the skin and subcutaneous tissue

2340

10695

1.10

4.42

1.7

1.6

4.85

3.51

mg/l

3.51

1748

7462

Volume depletion

837

0.53

4.39

3.0

1.7

5.55

4.20

mg/l

0.18

597

Other psoriatic arthropathies

1494

0.65

4.38

1.5

1.7

3.92

4.22

mg/l

0.17

1106

Crohn disease (strict definition, require KELA, min 2 HDR)

1086

0.59

4.37

1.3

1.7

4.02

4.55

mg/l

0.27

762

Hernia of abdominal wall, postoperative

321

2524

1.28

4.37

1.7

1.6

6.85

2.95

mg/l

1.73

274

1777

Substance abuse

888

9607

0.86

4.33

1.6

4.83

3.84

mg/l

2.03

771

6820

Abdominal and pelvic pain

2246

10274

1.10

4.31

1.7

1.6

4.44

3.58

mg/l

1.87

1711

7150

Viral infections characterized by skin and mucous membrane lesions

1832

14172

1.11

4.31

1.8

1.6

4.11

3.84

mg/l

0.44

1368

10158

Acute tubulo-interstitial nephritis

901

8942

0.87

4.31

1.8

1.6

4.76

3.66

mg/l

2.10

701

6404

Paroxysmal tachycardia

503

3478

1.22

4.29

3.7

1.4

4.54

3.44

mg/l

1.25

394

2359

Presence of other functional implants

622

5115

0.84

4.28

1.6

1.5

3.88

3.37

mg/l

0.62

499

3747

Crohn's disease of large intestine

839

0.54

4.28

1.5

1.7

4.63

4.45

mg/l

0.04

605

Other and unspecified polyneuropathies, also in other diseases

248

1892

1.32

4.25

1.6

1.7

3.84

3.97

mg/l

0.06

199

1405

Emotional disorders starting during childhood or adolecense, excluding more controls

114

745

1.52

4.24

1.4

1.5

4.94

3.48

mg/l

1.11

440

Implicit bacterial Sepsis

424

4483

0.81

4.23

2.2

1.6

8.67

3.55

mg/l

6.52

371

3251

Focal epilepsy, strict definition

195

2619

0.74

4.23

1.6

1.7

6.32

3.93

mg/l

0.98

153

1892

Other sexually transmitted chlamydial diseases

196

1452

1.37

4.22

1.5

1.7

3.37

4.10

mg/l

1.07

149

986

Other inflammation of eyelid

237

1802

1.33

4.20

1.5

1.7

3.80

3.77

mg/l

0.01

181

1307

Other diseases of urinary system

2173

11131

1.10

4.19

1.7

1.6

4.12

3.82

mg/l

0.56

1643

7967

Transient ischemic attack

490

4785

0.83

4.18

1.8

1.7

3.59

3.89

mg/l

0.35

368

3557

Malignant neoplasm of ovary, including Hilmo

756

0.52

4.17

1.6

8.35

3.83

mg/l

0.59

564

Wide developmental disorders

543

1.62

4.17

1.5

1.6

3.01

3.81

mg/l

0.76

356

Mucosal proctocolitis

159

2196

0.72

4.17

1.6

1.7

3.81

4.12

mg/l

0.24

125

1568

Speech and linguistic disorders, excluding more controls

174

1188

1.39

4.17

1.5

5.20

3.61

mg/l

0.93

136

720

Other and unspecified disorders of vitreous body

618

5152

1.19

4.16

1.7

3.74

3.80

mg/l

0.04

451

3866

Voice disturbances

457

3761

1.22

4.15

1.6

1.7

3.35

3.89

mg/l

0.77

337

2793

Other special examinations and investigations of persons without complaint or reported diagnosis

1465

6621

1.12

4.15

1.7

1.6

4.59

3.69

mg/l

1.78

1121

4509

Other diseases of blood and blood-forming organs, wide

219

2882

0.75

4.12

1.9

1.7

7.42

3.77

mg/l

2.02

187

2114

Nasal polyp

304

2394

1.28

4.11

1.5

1.7

4.24

4.05

mg/l

0.12

245

1716

Dissociative [conversion] disorders

650

1.56

4.10

1.4

1.6

3.30

4.20

mg/l

0.38

426

Polyneuropathies and other disorders of the peripheral nervous system

286

2236

1.29

4.09

1.5

1.7

4.40

4.05

mg/l

0.16

231

1670

Fissure and fistula of anal and rectal regions

445

3659

1.22

4.08

1.7

3.66

3.59

mg/l

0.05

347

2605

Missing teeth due to accident, extraction or parodontitis

719

7882

0.86

4.08

1.7

4.95

3.82

mg/l

0.87

594

5794

Early onset COPD, excluding more controls

198

2638

0.75

4.08

1.8

1.4

9.63

3.09

mg/l

4.59

170

1842

Polycystic ovarian syndrome

179

1317

1.39

4.07

1.6

5.05

3.81

mg/l

1.42

144

895

Hypertensive Heart Disease

172

1840

0.73

4.07

1.7

1.6

3.76

3.61

mg/l

0.05

149

1292

Undetermined asthma, excluding more controls

247

1897

1.31

4.06

1.7

1.4

5.84

3.03

mg/l

3.11

210

1295

Nontraumatic intracranial haemmorrhage

127

1817

0.69

4.06

1.7

5.60

4.09

mg/l

0.45

1358

Medical treatment for female infertility

609

5134

1.19

4.06

1.6

4.17

3.85

mg/l

0.36

425

3677

Symptoms and signs involving the digestive system and abdomen

2244

10274

1.10

4.04

1.7

1.6

4.80

3.58

mg/l

2.97

1723

7150

ILD medications: prednisolone, methylprednisolone, prednisone

2456

12613

1.09

4.04

2.6

1.4

5.48

3.38

mg/l

10.41

2023

8769

Implicit Sepsis

1276

10454

0.89

4.03

2.1

1.6

6.32

3.58

mg/l

7.65

1042

7541

Nonischemic cardiomyopathy

136

952

1.44

4.01

5.3

1.7

6.07

4.03

mg/l

0.84

126

701

Undetermined asthma

247

1902

1.31

3.99

1.7

1.4

5.84

3.05

mg/l

3.06

210

1305

Fibromyalgia

220

1672

1.33

3.98

1.5

1.7

4.05

4.12

mg/l

0.04

194

1160

Chronic pancreatitis

1404

0.66

3.98

1.5

1.7

5.36

3.45

mg/l

0.55

1023

MS-disease / Multiple Sclerosis

1327

0.65

3.98

1.6

1.7

5.35

4.25

mg/l

0.36

958

Adverse effects, not elsewhere classified

425

3493

1.23

3.96

1.6

1.7

4.92

4.00

mg/l

0.80

323

2521

Disorders of vitreous body

743

6186

1.16

3.93

1.7

3.64

3.81

mg/l

0.19

554

4622

Malignant neoplasm of prostate

222

1745

0.76

3.93

1.4

1.7

3.15

4.23

mg/l

1.27

168

1258

Procedures for purposes other than remedying health state

375

1.73

3.93

1.5

1.6

2.62

4.45

mg/l

0.61

274

Agranulocytosis

1407

0.66

3.88

1.9

1.7

11.22

3.88

mg/l

1.64

1034

Condition for Implicit Sepsis (Organ dysfunction codes)

1387

10897

0.90

3.87

2.1

1.6

6.18

3.57

mg/l

7.25

1119

7866

Other pleural conditions

791

0.55

3.86

1.6

1.7

6.13

3.67

mg/l

0.56

587

Ulcerative ileocolitis

669

0.51

3.86

2.1

1.8

2.97

4.02

mg/l

0.84

486

Candidiasis

255

1985

1.30

3.84

1.7

6.55

4.06

mg/l

1.45

190

1446

Other predominantly sexually transmitted diseases, not elsewhere classified

437

3620

1.22

3.81

1.5

1.6

3.45

4.05

mg/l

0.62

337

2549

Pustular psoriasis

626

0.50

3.78

1.5

1.7

3.33

4.19

mg/l

0.33

459

Renal failure

385

4152

0.82

3.76

2.4

1.6

8.58

3.69

mg/l

4.98

353

3035

Heart failure, not strict

989

7612

0.88

3.76

3.1

1.6

6.61

3.58

mg/l

5.55

898

5540

Other/unspecified rheumatoid arthritis

1266

0.65

3.75

1.6

9.42

3.62

mg/l

1.26

959

Gluteal tendinitis

535

1.58

3.75

1.5

1.7

3.33

4.21

mg/l

0.34

392

Epilepsy

359

4388

0.81

3.74

1.6

5.46

3.59

mg/l

1.43

274

3001

Demyelinating diseases of the central nervous system

106

1535

0.68

3.74

1.6

1.7

4.69

4.33

mg/l

0.12

1110

Combinations of oral blood glucose lowering drugs

280

3524

0.79

3.72

2.1

1.7

4.61

4.00

mg/l

0.35

250

2547

Migraine with aura and triptan purchases

403

3321

1.23

3.71

1.8

1.6

4.11

4.07

mg/l

0.03

314

2332

Endometriosis of intestine

285

1.81

3.67

1.9

1.8

3.45

3.24

mg/l

0.09

184

Other disorders of penis

131

928

1.42

3.66

1.6

1.7

3.94

3.95

mg/l

0.00

106

652

Retention of urine

285

2937

0.79

3.65

1.5

1.7

4.30

3.95

mg/l

0.17

229

2154

Crohn disease

163

2191

0.74

3.64

1.7

4.29

4.04

mg/l

0.15

128

1568

Superficial injury of lower leg

485

4071

1.20

3.64

1.8

1.6

3.93

3.99

mg/l

0.06

387

2881

Disorders of vitreous body and globe

758

6326

1.16

3.63

1.7

3.64

3.84

mg/l

0.22

566

4727

Crohn's disease NAS

1022

0.62

3.63

1.4

1.8

4.73

4.33

mg/l

0.13

731

Autoimmune diseases related-to ILD

1501

14161

0.90

3.61

1.7

1.6

4.71

3.56

mg/l

3.40

1178

10125

6-mercaptopurine

601

0.51

3.61

1.4

1.5

4.42

4.65

mg/l

0.05

423

Ethmoidectomy

252

1977

1.29

3.61

1.6

1.7

4.25

3.91

mg/l

0.21

203

1443

Nonalcoholic fatty liver disease

191

1445

1.34

3.60

1.8

1.7

4.14

4.27

mg/l

0.08

171

1060

Implicit bacterial Sepsis

376

4053

0.82

3.59

2.2

1.6

8.95

3.60

mg/l

5.97

331

2948

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

243

3091

0.78

3.59

1.6

1.7

3.86

4.01

mg/l

0.12

182

2203

Dental operations

1072

6205

0.88

3.59

1.7

1.6

4.68

3.33

mg/l

1.50

805

4373

Chronic gastritis

347

2822

1.24

3.58

1.8

1.7

5.74

3.51

mg/l

0.76

276

2054

Impacted cerumen

134

958

1.41

3.58

1.5

1.7

4.22

3.77

mg/l

0.09

703

Mycoses

1806

14353

1.10

3.57

1.7

1.6

3.89

3.84

mg/l

0.09

1327

10307

Myocardial infarction, unclassifiable

1247

0.68

3.54

1.9

1.7

6.33

4.12

mg/l

0.49

932

Schizoaffective disorder

1317

0.67

3.54

1.8

1.7

4.07

4.02

mg/l

0.02

949

Drug-induced neutropenia

880

0.59

3.53

1.9

1.7

7.59

4.01

mg/l

0.75

644

FESS (DNB20)

243

1904

1.29

3.53

1.6

1.7

4.17

3.91

mg/l

0.15

194

1392

Other pulmonary diagnosis

1895

8671

1.10

3.52

1.8

1.4

4.94

3.18

mg/l

4.68

1452

5954

Unspecific neurodegenerative disorder

199

1780

0.76

3.50

1.4

1.6

3.15

3.68

mg/l

0.36

151

1336

Anogenital herpesviral [herpes simplex] infection

286

2290

1.26

3.50

1.6

1.7

3.81

4.28

mg/l

0.31

207

1594

Bruxism

312

1.75

3.50

1.5

1.7

3.85

3.18

mg/l

0.36

218

5-aminosalicylic acid

310

3824

0.81

3.49

1.5

4.11

3.66

mg/l

0.51

231

2681

Speech therapy

274

3427

0.79

3.48

1.5

1.7

3.98

4.00

mg/l

0.01

204

2530

Malignant neoplasm of colon, including Hilmo

121

1693

0.71

3.48

1.4

1.7

4.72

3.82

mg/l

0.32

102

1246

Other obstetric conditions, not elsewhere classified

1009

5694

1.13

3.46

1.6

3.97

3.94

mg/l

0.05

732

3963

Pustulosis palmaris et plantaris

580

0.51

3.45

1.4

1.7

3.30

4.25

mg/l

0.34

421

Conductive and sensorineural hearing loss

1086

8208

0.89

3.43

1.6

1.7

4.10

3.90

mg/l

0.20

797

6092

Postmenopausal bleeding

392

1716

1.23

3.42

1.8

1.7

3.95

4.22

mg/l

0.20

305

1316

Diseases of external ear

572

4898

1.17

3.40

1.6

1.7

4.56

3.89

mg/l

0.53

441

3533

Schizophrenia or delusion, excluding more controls

442

5204

0.84

3.40

1.6

1.7

4.39

3.84

mg/l

0.79

369

3495

Myocardial infarction, without ST-elevation

278

3156

0.80

3.37

2.4

1.6

4.52

4.01

mg/l

0.26

222

2351

Kela-code for behavioural disturbances in mental retardation

0.00

3.37

0.0

1.7

—

3.83

—

Abnormal findings on examination of blood, without diagnosis

685

5456

1.16

3.37

1.7

5.72

3.93

mg/l

2.86

561

3975

Ulcerative colitis (strict definition, require KELA)

227

2886

0.78

3.37

1.6

1.7

3.93

3.94

mg/l

0.01

173

2058

Other and unspecified disorders of autonomic nervous system

2.98

3.37

1.7

1.4

7.29

3.50

mg/l

—

Necrosis of pulp, including avohilmo

1044

11645

0.89

3.37

1.7

1.6

4.70

3.87

mg/l

0.84

830

8379

Malignant neoplasm of brain, including Hilmo

627

0.53

3.35

1.3

1.7

2.58

4.79

mg/l

1.32

448

Hypo-osmolality and hyponatraemia

119

1650

0.71

3.35

2.4

1.7

5.18

3.60

mg/l

0.74

1184

Adenocarcinoma of pancreas

223

0.31

3.35

1.0

1.7

7.63

3.47

mg/l

—

169

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

991

5591

1.13

3.34

1.6

4.00

3.95

mg/l

0.06

722

3887

Spondylosis

721

6731

0.87

3.33

1.8

1.7

4.11

3.83

mg/l

0.26

563

4948

Disorders of other endocrine glands

819

7089

1.14

3.33

1.7

1.6

4.51

3.75

mg/l

1.39

641

5048

Mycoses

455

3832

1.19

3.32

1.7

5.57

3.96

mg/l

1.59

346

2774

Contact with and exposure to communicable diseases

623

7156

0.86

3.31

1.5

1.6

3.70

3.87

mg/l

0.13

418

4996

Disorders of eyelid, lacrimal system and orbit

1640

11367

1.10

3.30

1.7

1.6

3.68

3.95

mg/l

0.53

1257

8290

Non-small cell lung cancer, adenocarcinoma

480

0.47

3.30

2.1

1.7

4.20

3.91

mg/l

0.05

358

Certain infectious and parasitic diseases

2315

10714

1.08

3.30

1.8

1.6

4.67

3.46

mg/l

3.24

1764

7468

Malignant neoplasm of eye, brain and central nervous system

545

0.51

3.30

1.4

1.8

3.53

4.89

mg/l

0.46

392

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

219

2788

0.78

3.30

1.6

1.7

3.96

3.98

mg/l

0.01

167

1990

887

7788

1.13

3.30

1.8

1.6

5.57

3.60

mg/l

4.41

713

5488

Aplastic and other anaemias

424

4708

0.84

3.29

1.8

1.7

6.60

3.86

mg/l

3.08

356

3446

Urticaria

636

5509

1.16

3.29

1.7

1.6

4.19

3.83

mg/l

0.41

497

3942

Mild mental retardation

366

0.40

3.29

1.9

1.6

5.91

3.48

mg/l

0.77

253

Hyperhidrosis

513

1.55

3.29

1.7

1.5

3.91

2.98

mg/l

0.63

348

Other septicaemia

367

4257

0.83

3.28

2.2

1.6

6.06

3.68

mg/l

2.51

315

3065

Malignant neoplasm of brain

449

0.46

3.27

1.2

1.8

2.45

3.99

mg/l

1.12

323

Malignant neoplasm of ovary

556

0.51

3.26

1.5

1.7

10.11

4.10

mg/l

0.56

407

Colorectal adenocarcinoma

126

1727

0.72

3.26

1.3

1.7

3.52

3.82

mg/l

0.16

106

1273

Malignant neoplasm of rectum, including Hilmo

1130

0.66

3.25

1.2

1.7

2.98

4.19

mg/l

0.79

839

Implicit viral Sepsis

432

3627

1.20

3.25

2.3

1.6

7.64

3.66

mg/l

4.24

356

2591

Hypersomnia

208

1.89

3.22

1.4

1.8

2.99

3.75

mg/l

0.36

149

Multiple myeloma, including Hilmo

364

0.41

3.20

1.3

1.7

1.16

2.99

mg/l

—

272

Need for immunization against other single viral diseases

252

1.79

3.20

1.9

3.94

3.63

mg/l

0.08

186

Artificial opening status

578

0.53

3.18

1.8

1.5

4.62

3.92

mg/l

0.18

429

Hyperplasia of prostate

466

2226

1.19

3.17

1.7

4.22

4.25

mg/l

0.01

351

1634

Symptoms and signs involving speech and voice

532

4560

1.17

3.16

1.7

3.51

3.87

mg/l

0.49

400

3367

Kidney diseases associated to Fabry's disease

4.34

3.13

3.9

1.7

1.25

2.69

mg/l

—

Exclusions for E4_PCOS_CONSORTIUM

1688

9682

1.10

3.13

1.6

3.70

3.81

mg/l

0.20

1285

6957

Benign neoplasms

2260

11539

1.08

3.11

1.6

3.79

3.87

mg/l

0.12

1663

8191

Other disorders of eyelid

592

4873

1.16

3.10

1.6

1.7

2.95

3.78

mg/l

1.96

454

3610

Acute and transient psychotic disorders

145

1929

0.74

3.09

1.6

1.7

4.32

3.99

mg/l

0.16

117

1397

Alcohol-induced chronic pancreatitis

762

0.60

3.09

1.5

1.8

8.15

5.00

mg/l

0.42

561

Premenstrual syndrome

204

1.88

3.09

1.6

1.7

4.19

3.81

mg/l

0.10

136

Other general symptoms and signs

113

801

1.42

3.09

1.6

6.76

4.17

mg/l

0.58

542

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

136

986

1.37

3.09

1.6

4.54

3.74

mg/l

0.64

642

Lung diseases due to external agents

1165

0.67

3.08

2.0

1.7

9.70

4.26

mg/l

1.28

859

Diabetic retinopathy, strict definition

223

1552

1.28

3.07

1.5

2.1

4.19

4.99

mg/l

0.82

208

1387

Inflammatory bowel disease

472

5528

0.85

3.06

1.6

1.7

3.88

3.94

mg/l

0.07

363

3981

Diseases of the musculoskeletal system and connective tissue

1466

6686

1.10

3.06

1.7

1.5

4.17

3.54

mg/l

1.34

1108

4390

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1333

9589

1.10

3.04

1.7

1.6

3.85

3.86

mg/l

0.01

939

6995

Multiple myeloma and malignant plasma cell neoplasms

355

0.42

3.03

1.3

1.6

1.16

3.10

mg/l

—

285

Herpesviral [herpes simplex] infections

527

4535

1.17

3.02

1.7

1.6

3.58

3.90

mg/l

0.34

380

3295

Crohn disease (strict definition, all UC cases excluded)

842

0.62

3.02

1.3

1.7

4.27

4.76

mg/l

0.20

598

Asthma (diagnoses ohter than nonallergic)

1800

13753

1.09

3.02

1.8

1.6

5.15

3.66

mg/l

3.64

1439

9774

Cardiovascular diseases (excluding rheumatic etc)

1811

9582

1.09

3.01

2.2

1.4

4.65

3.39

mg/l

2.89

1444

6430

Other noninflammatory disorders of vulva and perineum

189

1468

1.30

3.00

1.6

1.7

2.75

4.03

mg/l

2.41

127

1043

Non-small cell lung cancer, adenocarcinoma, helper endpoint

462

0.49

2.99

2.1

1.7

4.20

3.85

mg/l

0.06

363

Intentional self-harm by unspecified means

229

1.81

2.97

1.7

3.68

4.05

mg/l

0.14

156

Testicular hypofunction

397

1.59

2.96

2.2

1.8

5.04

4.29

mg/l

0.11

294

Other disorders of skin and subcutaneous tissue, not elsewhere classified

214

1690

1.28

2.96

1.7

5.11

4.12

mg/l

0.52

173

1243

Intestinal infectious diseases

1989

13968

1.08

2.94

1.8

1.6

5.09

3.65

mg/l

3.39

1544

9906

Hypertrophic cardiomyopathy

437

1.56

2.94

4.3

1.8

6.14

3.54

mg/l

1.20

328

Other/unspecified enthesopathies of lower limb, excluding foot

147

1107

1.34

2.94

1.7

1.6

3.81

4.34

mg/l

0.31

112

794

Blepharochalasis

378

3170

1.20

2.94

1.6

1.7

2.49

3.69

mg/l

2.92

295

2368

Female infertility, associated with anovulation

227

1813

1.27

2.92

1.7

1.6

4.50

3.98

mg/l

0.39

174

1224

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

874

0.64

2.91

1.2

1.6

3.01

4.23

mg/l

0.57

645

Non-Hodgkin lymphoma, all, including Hilmo

1314

0.70

2.90

1.4

1.6

4.46

4.07

mg/l

0.15

964

GI-bleeding

278

3396

0.82

2.90

1.6

1.7

6.67

3.83

mg/l

0.87

223

2487

Hypertensive Renal Disease

291

0.37

2.90

1.2

1.6

3.23

3.15

mg/l

0.01

214

Ulcerative colitis

349

4168

0.83

2.89

1.6

1.7

3.77

3.96

mg/l

0.20

271

2989

Injuries to the head

2127

14071

0.93

2.88

1.7

1.6

3.95

3.84

mg/l

0.17

1626

10025

Lateral epicondylitis

174

2234

0.77

2.87

1.6

1.7

4.34

3.94

mg/l

0.22

145

1603

Dysplasia of cervi uteri

571

3586

1.16

2.85

1.7

1.6

3.52

4.06

mg/l

0.83

400

2528

Benign neoplasm: Testis

3.74

2.84

1.2

1.6

1.96

2.99

mg/l

—

Anorexia (incl.atypical)

147

1114

1.34

2.83

1.5

1.6

2.64

4.32

mg/l

1.57

104

750

Sphingolipidosis, other/unspecified

3.84

2.82

3.9

1.6

1.25

2.50

mg/l

—

Other and unspecified urticaria

401

3398

1.19

2.82

1.7

4.30

4.02

mg/l

0.22

321

2454

Disorder of lipoprotein metabolism, unspecified

159

1217

1.31

2.81

2.0

1.7

4.60

3.98

mg/l

0.18

139

880

Ulcerative rectosigmoiditis

1337

0.71

2.80

1.9

1.7

3.52

4.14

mg/l

0.34

972

Injury of muscle and tendon at shoulder and upper arm level

525

4543

1.16

2.80

1.6

1.7

3.95

3.91

mg/l

0.03

423

3343

Rosacea

215

1715

1.27

2.78

1.7

3.78

3.83

mg/l

0.03

176

1259

Urticaria and erythema

741

6570

1.13

2.77

1.7

1.6

4.14

3.84

mg/l

0.36

581

4706

Contraceptive management

1006

6351

1.12

2.77

1.6

1.7

3.87

4.04

mg/l

0.20

754

4708

Adenocarcinoma and papilloma adenocarcinoma of rectum

838

0.64

2.76

1.2

1.6

3.06

4.35

mg/l

0.59

618

Impotence

460

1.52

2.75

1.6

1.8

2.42

4.58

mg/l

1.79

332

Other disorders of skin and subcutaneous tissue

1177

9504

1.10

2.73

1.7

4.71

3.81

mg/l

1.48

940

6945

Malignant neoplasm of prostate, including Hilmo

254

1858

0.81

2.73

1.4

1.8

3.51

4.18

mg/l

0.50

187

1349

Abdominal aortic aneurysm (AAA)

470

0.52

2.72

1.8

1.6

6.35

3.19

mg/l

0.53

349

Other noninflammatory disorders of vagina

146

1113

1.33

2.70

1.9

1.7

3.53

3.94

mg/l

0.18

106

795

Intracerebral haemorrhage

955

0.67

2.70

1.6

5.28

4.29

mg/l

0.19

709

Suppurative and necrotic conditions of lower respiratory tract

548

0.56

2.70

1.6

1.8

5.08

4.63

mg/l

0.10

400

Other diseases of anus and rectum

441

3770

1.17

2.69

1.9

1.7

3.71

3.69

mg/l

0.01

354

2700

Non-invasive ventilation

353

3736

0.84

2.69

1.7

1.4

9.62

3.04

mg/l

8.11

281

2360

Pyothorax

430

0.51

2.68

1.8

1.7

4.16

5.05

mg/l

0.19

324

Endometriosis ASRM stages 3,4

464

3998

1.17

2.67

1.6

1.7

3.59

3.75

mg/l

0.15

322

2939

Colonic or urogenital fistula

457

3931

1.17

2.67

1.7

3.73

3.91

mg/l

0.13

356

2860

Other bacterial intestinal infections

365

3084

1.19

2.66

1.7

1.6

5.11

3.45

mg/l

1.54

282

2215

Disorders of thyroid, IBD co-morbidities

466

2815

1.17

2.65

2.2

1.5

4.20

2.89

mg/l

2.22

377

1748

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

689

6105

1.13

2.64

1.6

4.42

3.86

mg/l

1.06

576

4268

Complications of medical and surgical care

1373

11577

1.09

2.64

1.8

1.6

4.57

3.82

mg/l

1.85

1116

8390

Thyroiditis, unspecified

215

1.77

2.62

1.8

3.37

3.04

mg/l

0.13

157

Acute alcohol intoxication ICD-9

359

0.47

2.61

1.2

1.8

11.85

3.61

mg/l

0.73

272

Suggestive for eosinophilic asthma

150

1154

1.31

2.61

1.7

6.00

3.59

mg/l

1.19

126

836

Other joint disorders

2153

10578

1.08

2.61

1.7

1.6

4.45

3.66

mg/l

2.21

1642

7273

Follicular lymphoma, hilmo

399

0.49

2.61

1.3

1.7

5.62

4.66

mg/l

0.11

305

Supernumerary teeth EXCLUDE clefts and syndromes

2.74

2.60

1.1

1.5

5.60

4.08

mg/l

—

Golimumab

600

0.59

2.57

1.3

1.8

5.85

4.43

mg/l

0.23

434

Alzheimer disease

119

1163

0.75

2.56

1.5

1.6

3.29

3.55

mg/l

0.11

897

Crohn's disease of small intestine

1162

0.71

2.55

1.9

1.8

4.30

4.47

mg/l

0.07

825

Alzheimer disease, including avohilmo

153

1390

0.77

2.54

1.4

1.6

2.85

3.49

mg/l

0.38

115

1063

Actinic keratosis

331

2574

1.19

2.54

1.8

1.6

3.55

3.64

mg/l

0.05

247

1923

Diabetes mellitus in pregnancy

982

5683

1.11

2.53

1.7

1.6

4.27

3.90

mg/l

0.74

807

3933

Total colectomy

572

0.59

2.51

1.4

1.8

3.62

3.83

mg/l

0.10

418

Total colectomy operation

572

0.59

2.51

1.4

1.8

3.62

3.83

mg/l

0.10

418

Secondary and unspecified malignant neoplasm of lymph nodes

890

0.67

2.51

1.3

1.8

3.75

4.48

mg/l

0.33

637

Spinal stenosis

578

4991

0.88

2.50

1.6

1.7

3.33

3.87

mg/l

0.72

468

3675

Other predominantly sexually transmitted diseases, not elsewhere classified

521

4555

1.15

2.50

1.5

1.6

3.35

4.04

mg/l

0.92

396

3154

Non-selective monoamine reuptake inhibitors

578

4897

1.14

2.49

1.6

1.7

4.00

3.83

mg/l

0.14

486

3493

Pruritus

193

1543

1.26

2.49

1.6

4.65

3.52

mg/l

0.77

161

1125

Asymptomatic human immunodeficiency virus [HIV] infection status

2.28

2.49

1.3

1.5

2.49

4.03

mg/l

0.46

Parkinson's disease, excluding more controls

1082

0.71

2.47

1.5

1.95

4.08

mg/l

3.73

745

Hydrocephalus

670

0.62

2.47

1.5

1.6

8.35

3.92

mg/l

0.56

505

Other functional intestinal disorders

751

6227

1.12

2.46

1.6

1.7

3.80

3.65

mg/l

0.19

588

4456

Amenorrhoea

173

1370

1.28

2.45

1.7

1.6

4.12

4.07

mg/l

0.04

126

934

Injuries to the hip and thigh

529

5466

0.87

2.45

1.5

1.7

4.22

3.89

mg/l

0.33

420

3939

Anisometropia and aniseikonia

368

1.55

2.44

1.4

1.6

2.33

4.63

mg/l

0.87

275

Gout

217

2347

0.81

2.44

2.2

1.7

5.87

3.89

mg/l

1.55

191

1665

Follow-up care involving plastic surgery

557

1.44

2.44

1.6

3.36

4.04

mg/l

0.25

407

Malignant neoplasm of rectum

861

0.67

2.44

1.3

1.6

3.03

4.31

mg/l

0.62

632

Disorders of lens

935

6453

0.90

2.43

1.8

1.7

5.60

3.78

mg/l

1.89

737

4794

Other anaemias

394

4359

0.86

2.42

1.7

6.28

3.80

mg/l

2.83

331

3195

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

177

0.33

2.42

1.3

1.7

3.39

2.72

mg/l

—

134

Erectile dysfunction

523

1.44

2.41

2.7

1.6

10.79

3.12

mg/l

2.55

374

Other and unspecified anaemias

389

4317

0.86

2.41

1.7

1.6

6.29

3.80

mg/l

2.81

327

3161

Follow-up examination after treatment for malignant neoplasms

1036

0.70

2.41

1.7

1.6

6.33

3.52

mg/l

0.50

744

Problems related to lifestyle

140

1800

0.77

2.41

1.6

5.30

3.59

mg/l

1.81

124

1250

Hyperkinetic disorders (excl. ADHD)

280

1.63

2.39

1.2

1.7

5.42

3.06

mg/l

0.91

185

Ovarian dysfunction

211

1716

1.24

2.39

1.6

4.77

4.13

mg/l

0.52

170

1188

Coxarthrosis [arthrosis of hip](FG)

698

5507

0.89

2.39

1.7

1.6

4.13

3.59

mg/l

0.56

568

3971

Other diseases of pancreas

856

0.67

2.38

1.3

1.8

6.87

3.40

mg/l

0.62

621

Persistent delusional disorders

938

0.69

2.38

1.6

1.7

3.89

4.09

mg/l

0.07

697

Other ulcerative colitis

913

0.68

2.38

1.4

1.7

4.25

4.42

mg/l

0.05

664

Gingivitis and periodontal diseases

1967

10874

0.93

2.37

1.8

1.6

4.82

3.49

mg/l

2.96

1490

7703

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

934

6506

0.90

2.36

1.8

1.4

3.97

3.39

mg/l

0.98

734

4495

Anogenital herpesviral [herpes simplex] infection

159

1254

1.28

2.36

1.6

1.7

2.66

4.59

mg/l

2.56

120

867

Alzheimer disease, excluding more controls

100

891

0.74

2.35

1.5

3.39

3.61

mg/l

0.08

631

Disorders of muscle in diseases classified elsewhere

5.13

2.35

8.3

1.8

3.35

3.65

mg/l

—

Disorders of psychological development

273

2112

1.21

2.34

1.5

4.52

3.85

mg/l

0.49

217

1396

Ulcerative colitis (strict definition, all Crohn cases excluded)

197

2426

0.81

2.34

1.6

1.7

3.74

4.03

mg/l

0.24

150

1727

Juvenile arthritis (FINNGEN)

861

0.68

2.33

1.5

1.6

4.17

4.58

mg/l

0.14

574

Endometriosis ASRM stages 1,2

403

3481

1.17

2.32

1.6

1.7

3.64

3.81

mg/l

0.21

299

2531

Any reimbursement code in KELA

1582

8553

0.92

2.32

1.7

1.5

5.01

3.05

mg/l

4.95

1233

5581

Generalized epilepsy

717

0.65

2.32

1.3

1.7

3.72

3.70

mg/l

0.01

507

Convulsions, not elsewhere classified

335

3878

0.85

2.31

1.7

1.5

3.81

3.79

mg/l

0.01

263

2641

Unspecified visual impairment (binocular)

169

0.35

2.31

2.3

1.8

0.61

2.68

mg/l

—

126

Left bundle-branch block

697

1.37

2.31

4.3

1.5

4.16

3.92

mg/l

0.06

500

Malignant neoplasm of colon

1282

0.74

2.31

1.4

1.6

4.17

3.95

mg/l

0.09

945

Substance abuse, excluding more controls

888

8350

0.90

2.31

1.6

4.83

3.83

mg/l

2.00

771

5682

Skin changes due to chronic exposure to nonionizing radiation

344

2700

1.18

2.30

1.8

1.6

3.49

3.62

mg/l

0.08

259

2020

Macular cyst

231

1.67

2.29

1.6

1.8

2.65

3.15

mg/l

0.20

188

Habitual aborter

383

1.52

2.29

2.0

1.8

2.41

3.30

mg/l

0.79

246

Chronic viral hepatitis

940

0.69

2.28

1.5

1.7

4.52

3.82

mg/l

0.33

661

Outcome of delivery

486

2624

1.15

2.28

1.5

1.6

3.00

4.38

mg/l

3.10

320

1916

Other and unspecified nonorganic psychotic disorders

318

3736

0.85

2.27

1.5

1.7

4.40

3.85

mg/l

0.62

269

2617

Other necrotizing vasculopathies

716

0.65

2.27

2.8

1.7

11.67

4.15

mg/l

0.94

534

Hydronephrosis

1278

0.74

2.27

1.6

5.93

3.71

mg/l

1.33

919

Physiological and behavioural disorders associated with sexual development and orientation

3.66

2.27

1.9

2.02

2.60

mg/l

—

Subarachnoid haemorrhage

1035

0.71

2.27

1.6

1.7

5.41

4.10

mg/l

0.25

765

Other and unspecified psoriasis

822

0.67

2.26

1.9

1.6

2.63

4.43

mg/l

1.48

603

Other disorders of bone

380

3273

1.17

2.26

1.6

1.7

5.35

3.90

mg/l

1.07

286

2354

Bronchitis

2286

13528

1.07

2.25

1.8

1.6

5.03

3.58

mg/l

6.38

1742

9617

Other diseases of the digestive system

289

3422

0.84

2.24

1.6

6.58

3.82

mg/l

0.89

233

2507

Other disorders starting during childhood or adolescence

121

918

1.32

2.24

1.4

1.6

4.32

3.81

mg/l

0.34

594

Complications of procedures, not elsewhere classified

1604

12341

1.08

2.24

1.8

1.6

4.33

3.81

mg/l

1.20

1294

8898

Ptosis of eyelid

140

1092

1.29

2.24

1.8

1.7

2.96

3.61

mg/l

0.36

108

814

Transport accidents

1040

8180

1.10

2.22

1.6

4.12

3.74

mg/l

0.60

768

5653

DVT of lower extremities

178

2203

0.80

2.21

1.8

1.7

3.52

4.09

mg/l

0.53

145

1616

Localized swelling, mass and lump of skin and subcutaneous tissue

531

4689

1.14

2.21

1.7

3.83

3.91

mg/l

0.07

386

3416

Maternal care for other known or suspected fetal problems

726

4127

1.12

2.20

1.5

1.6

4.26

4.08

mg/l

0.18

531

2894

Osteonecrosis

709

0.66

2.19

2.2

1.7

5.67

4.36

mg/l

0.38

527

Retinal detachment with retinal break

164

1308

1.26

2.19

1.8

1.7

3.85

4.07

mg/l

0.08

126

966

Inguinal or femoral hernia, bilateral

120

920

1.31

2.18

1.8

1.7

5.24

3.18

mg/l

0.61

676

Cystic kidney disease

450

0.57

2.18

1.8

1.7

2.41

3.14

mg/l

0.55

324

Diseases of the respiratory system

1497

6947

1.08

2.18

1.7

1.5

4.75

3.05

mg/l

3.56

1121

4791

Cholelithiasis

1582

10140

1.08

2.17

1.8

1.7

4.87

3.69

mg/l

2.44

1333

7355

Vulvovaginal ulceration/inflammation in other diseases

149

1180

1.28

2.17

1.7

1.6

3.89

4.21

mg/l

0.16

102

826

Malignant neoplasm of larynx, including Hilmo

149

0.33

2.16

1.2

1.5

10.44

4.07

mg/l

—

106

Enlarged lymph nodes

286

2420

1.19

2.14

3.3

1.6

3.53

3.75

mg/l

0.16

224

1686

Endometriosis of rectovaginal septum and vagina

129

1004

1.30

2.13

1.5

1.7

4.71

3.81

mg/l

0.40

714

Other dorsopathies, not elsewhere classified

2312

11390

1.06

2.12

1.6

4.00

3.76

mg/l

0.48

1759

7958

Colectomy operation

135

1714

0.78

2.12

1.5

1.7

4.48

3.90

mg/l

0.33

109

1268

Appendicitis, broad definition

1576

13285

1.08

2.11

1.7

1.6

3.51

3.91

mg/l

1.28

1187

9586

Other and unspecified diseases of spleen

0.00

2.10

0.0

1.8

—

6.25

—

Infective dermatitis

113

1464

0.77

2.10

1.7

5.81

3.41

mg/l

0.81

1061

Heart failure and coronary heart disease

342

2818

0.86

2.09

4.1

1.5

6.65

3.29

mg/l

3.91

315

2063

Hypothyroidism, drug reimbursement

356

2163

1.17

2.08

1.9

1.3

3.99

3.25

mg/l

1.17

298

1332

Erosion of teeth , including avohilmo

524

4646

1.13

2.08

1.6

3.83

3.97

mg/l

0.10

382

3298

Spermatocele

565

1.39

2.08

1.5

1.8

3.78

4.33

mg/l

0.13

403

Complications associated with artificial fertilization

327

1.53

2.07

1.3

1.7

2.54

3.30

mg/l

0.74

209

Diseases of appendix

1584

13322

1.07

2.06

1.7

1.6

3.55

3.90

mg/l

1.04

1194

9611

Soft tissue disorders related to use, overuse and pressure

447

3924

1.14

2.06

1.9

1.7

4.20

3.99

mg/l

0.14

365

2778

Otitis media, unspecified

165

1877

0.80

2.06

1.5

4.46

4.12

mg/l

0.13

132

1263

Other diseases of biliary tract

828

0.70

2.04

1.5

1.7

7.63

3.30

mg/l

0.66

604

Hallux valgus (acquired)

466

3804

0.88

2.04

1.6

1.7

3.04

3.58

mg/l

0.86

344

2730

Duodenal ulcer

852

0.70

2.04

1.5

1.7

5.48

3.00

mg/l

0.68

619

Traumatic subdural haemorrhage

1028

0.73

2.02

1.7

1.6

3.15

3.89

mg/l

0.44

722

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

629

1.37

2.02

1.8

1.7

4.17

3.88

mg/l

0.09

472

Varicose veins

812

6744

0.91

2.01

1.8

1.7

3.77

3.92

mg/l

0.16

625

5050

severe traumatic brain injury, does not include concussion

177

2167

0.81

2.01

1.9

1.7

2.91

4.16

mg/l

1.73

126

1593

Unspecified kidney failure

779

0.69

2.01

2.7

1.7

9.47

3.77

mg/l

1.23

571

Toxic effect of ethanol

657

0.66

2.00

1.5

1.7

4.72

4.20

mg/l

0.18

467

Female genital prolapse

489

2434

1.14

2.00

1.6

1.7

2.78

4.06

mg/l

4.64

384

1802

Impingement syndrome of shoulder

404

3532

1.15

2.00

1.7

1.6

4.04

3.96

mg/l

0.05

332

2534

Acute appendicitis

1490

12988

1.07

1.99

1.7

1.6

3.52

3.93

mg/l

1.28

1125

9372

Other diseases of liver

302

2585

1.17

1.99

1.7

3.91

4.06

mg/l

0.14

262

1884

Emotional disorders and disorders of social functioning with onset specific to childhood

124

955

1.29

1.98

1.4

1.5

4.98

3.59

mg/l

1.12

626

Diarrhoea and gastroenteritis of presumed infectious origin

1436

12046

1.08

1.98

1.9

1.6

4.98

3.61

mg/l

3.69

1138

8507

Disorders of ocular muscles, binocular movement, accommodation and refraction

968

8806

1.09

1.98

1.7

1.6

4.07

3.81

mg/l

0.30

717

6262

Cervicalgia

356

3087

1.16

1.98

1.7

3.56

3.93

mg/l

0.43

284

2216

Complications of labour and delivery

1434

7413

1.08

1.98

1.6

3.59

3.82

mg/l

0.49

1029

5361

Insulin, fast-acting

491

5528

0.88

1.97

1.8

1.7

5.00

3.75

mg/l

1.60

456

3944

Fibrosis and cirrhosis of liver

821

0.70

1.96

2.2

1.7

5.60

4.28

mg/l

0.57

611

Non-follicular lymphoma

845

0.71

1.96

1.4

1.7

3.14

3.92

mg/l

0.39

621

Other obstructive and reflux uropathy

618

0.66

1.95

1.5

1.6

3.69

3.41

mg/l

0.10

447

Additional codes for the location of defect, injury or illness

772

0.69

1.95

1.6

1.8

4.87

4.13

mg/l

0.17

551

Inguinal hernia, bilateral

116

902

1.29

1.94

1.8

1.7

4.56

3.20

mg/l

0.36

661

Viral warts

416

3654

1.14

1.94

1.7

1.6

4.51

3.91

mg/l

0.37

312

2606

Other and unspecified iron deficiency

495

4391

1.13

1.93

1.9

1.6

4.68

3.71

mg/l

1.14

395

3206

Other abnormal findings of blood chemistry

616

0.66

1.92

1.5

1.7

5.57

4.33

mg/l

0.34

438

Parkinson's disease

1096

0.74

1.92

1.5

1.7

1.95

3.68

mg/l

2.31

828

Other retinal disorders

764

6547

0.91

1.92

1.6

1.7

3.44

3.82

mg/l

0.65

612

4782

Generalized epilepsy, mode (most common among epilepsy diagnosis)

530

0.63

1.91

1.2

1.7

4.05

3.65

mg/l

0.16

378

Use of glatiramer acetate

329

0.53

1.90

1.3

1.7

5.11

3.12

mg/l

—

229

Malignant neoplasm of corpus uteri

734

0.69

1.90

1.4

1.6

3.86

3.82

mg/l

0.01

554

Other sexually transmitted chlamydial diseases

269

2295

1.18

1.90

1.5

1.6

3.25

4.12

mg/l

1.79

195

1509

Other viral hepatitis

1112

0.75

1.89

1.4

1.7

4.38

4.19

mg/l

0.07

786

Other maternal disorders predominantly related to pregnancy

1402

8188

1.08

1.89

1.7

1.6

4.18

3.75

mg/l

0.87

1083

5821

429

0.59

1.88

1.3

1.7

4.91

3.22

mg/l

0.57

293

Artificial joint operation, meniscal resection

1574

9555

1.07

1.88

1.6

1.7

3.73

3.99

mg/l

0.46

1249

7010

L02BB Anti-androgens

457

0.61

1.88

1.5

1.6

3.10

3.38

mg/l

0.09

336

Lichen ruber planus, wide definition including periferal and oral lichen planus

330

2859

1.16

1.88

1.9

1.7

5.42

3.93

mg/l

1.23

260

2125

Postprocedural disorders of nervous system

168

1374

1.24

1.88

1.8

1.7

4.48

4.34

mg/l

0.04

134

980

Achilles tendinitis

181

1490

1.22

1.87

1.7

3.08

4.34

mg/l

1.35

150

1083

Striking against or struck by other objects

647

5841

1.11

1.86

1.7

1.6

4.02

3.99

mg/l

0.02

491

4102

Certolizumab pegol

352

0.56

1.86

1.3

1.8

3.85

3.28

mg/l

0.11

248

Other diseases of lip and oral mucosa

695

6304

1.11

1.86

1.7

3.77

3.83

mg/l

0.08

536

4568

Malignant neoplasm of stomach, including Hilmo

479

0.62

1.85

1.2

1.7

8.05

4.19

mg/l

0.79

350

Other necrotizing vasculopathies (FG)

623

0.67

1.85

2.0

1.7

11.81

4.34

mg/l

0.79

456

Opioids

2312

11362

1.06

1.84

1.7

1.6

4.53

3.46

mg/l

3.04

1876

7775

Disorders of synovium and tendon

1089

8822

1.08

1.84

1.6

3.67

3.89

mg/l

0.38

869

6196

Thyroiditis

133

1062

1.26

1.84

1.9

1.7

4.18

4.00

mg/l

0.06

102

764

Myocardial infarction, with ST-elevation

105

1347

0.78

1.83

2.7

1.7

3.64

4.19

mg/l

0.27

1002

Dorsopathies

2372

11416

1.06

1.83

1.6

3.86

3.76

mg/l

0.16

1790

7974

Poor fetal growth

255

2982

0.85

1.82

1.4

1.6

4.33

4.06

mg/l

0.18

173

2087

Crushed, pushed or stepped on by crowd or human stampede

159

1297

1.24

1.82

1.5

1.7

3.45

3.93

mg/l

0.38

106

892

Injury of muscle and tendon at lower leg level

246

2089

1.18

1.82

1.8

1.7

5.09

4.16

mg/l

0.36

178

1506

Other or unspecified ileus, impaction or obstruction

156

1909

0.81

1.81

1.6

1.7

7.22

3.33

mg/l

0.57

115

1401

Hypertrophic scar

109

852

1.29

1.81

1.4

1.7

4.35

4.52

mg/l

0.05

606

Use of interferon beta-1a

436

0.61

1.80

1.5

1.7

4.54

3.76

mg/l

0.18

308

Other and unspecified effects of external causes

569

5120

1.12

1.80

1.6

4.66

3.89

mg/l

0.90

435

3640

Thyrotoxicosis, other and/or unspecified

354

3095

1.15

1.79

2.4

1.6

3.90

4.05

mg/l

0.10

287

2224

Chronic conjunctivitis

388

1.44

1.78

1.5

1.9

4.30

4.71

mg/l

0.07

284

conjunctival haemorrhage

765

1.30

1.78

1.9

1.7

2.72

3.88

mg/l

0.64

567

Insulin, fast-acting or short human

495

5530

0.89

1.77

1.8

1.7

4.97

3.80

mg/l

1.47

460

3959

Pain associated with micturition

183

1518

1.21

1.77

1.5

1.7

3.59

3.83

mg/l

0.15

143

1101

Focal brain injury

746

0.71

1.77

1.5

1.7

2.85

3.82

mg/l

0.70

496

Low back pain

1637

11038

1.07

1.77

1.7

1.6

4.69

3.76

mg/l

2.23

1281

7750

Polycystic ovarian syndrome, broad definition

312

2712

1.16

1.76

1.7

1.6

4.50

4.06

mg/l

0.37

243

1859

Heartburn

187

1556

1.21

1.75

1.9

1.6

4.08

3.51

mg/l

0.36

147

1088

Malignant neoplasm of head and neck

768

0.71

1.75

1.3

1.8

4.62

4.43

mg/l

0.05

557

UC patients in KELA-register (code 208), prior to 1994

531

0.65

1.75

1.3

1.7

4.43

4.70

mg/l

0.05

396

Pneumonia derived septicemia

409

0.60

1.74

1.1

1.7

5.47

3.04

mg/l

0.79

301

Childhood asthma (age<16), excluding more controls

379

2625

1.14

1.74

1.5

1.3

4.70

3.22

mg/l

1.56

252

1598

Any operation in hilmo

117

468

1.29

1.74

1.7

1.3

3.91

2.66

mg/l

0.86

261

Memory loss

741

1.30

1.74

1.4

1.7

3.50

3.99

mg/l

0.20

568

Childhood asthma (age<16)

379

2627

1.14

1.74

1.5

1.4

4.70

3.29

mg/l

1.45

252

1604

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

917

0.74

1.73

1.5

1.6

5.51

4.54

mg/l

0.30

662

Shoulder lesions

1453

8234

1.07

1.73

1.6

1.7

3.77

3.93

mg/l

0.21

1157

5877

Type of accident

409

4614

0.88

1.73

1.7

4.35

3.89

mg/l

0.39

308

3309

Viral infections characterized by skin and mucous membrane lesions

747

6823

1.10

1.72

1.9

1.6

4.81

3.93

mg/l

0.89

577

4906

Other external causes of accidental injury

1913

9038

1.06

1.72

1.7

1.6

4.16

3.70

mg/l

0.66

1439

6287

Unspecified jaundice

469

0.63

1.71

1.4

1.7

3.62

3.40

mg/l

0.09

343

External causes of morbidity and mortality

1607

7556

1.07

1.71

1.7

1.6

4.28

3.58

mg/l

0.99

1204

5160

2432

11935

1.05

1.70

1.7

1.6

4.81

3.47

mg/l

6.43

1870

8390

Polycystic ovarian syndrome, consortium definition

1661

9255

1.07

1.69

1.7

1.6

4.33

3.65

mg/l

1.16

1297

6590

Injury of muscle and tendon at wrist and hand level

165

1991

0.82

1.69

1.5

1.7

5.08

3.91

mg/l

0.72

123

1429

Malignant neoplasm of bladder, including Hilmo

805

0.72

1.69

1.5

1.6

5.19

4.16

mg/l

0.30

579

Other peripheral vascular diseases

1071

0.76

1.69

1.9

1.7

4.17

3.88

mg/l

0.11

772

Secondary hypertension

1035

0.76

1.69

1.5

1.4

3.19

3.42

mg/l

0.12

697

Other specified and unspecified disorders of eye and adnexa

460

1.39

1.68

2.1

1.7

2.56

4.26

mg/l

0.71

337

Other symptoms and signs involving the digestive system and abdomen

282

2439

1.16

1.68

1.7

1.6

4.81

3.62

mg/l

0.90

213

1761

Traumatic amputation of wrist and hand

478

0.64

1.68

1.6

1.76

4.17

mg/l

3.02

358

Glaucoma

596

5661

0.90

1.68

1.7

4.02

3.83

mg/l

0.16

460

4205

Tic and related disorders

165

1.67

1.68

1.4

2.0

3.96

2.68

mg/l

0.62

Kela-code for severe mental illness

600

6615

0.90

1.68

1.6

1.7

4.06

3.86

mg/l

0.29

511

4693

Disorders of skin appendages

994

9199

1.08

1.68

1.6

4.46

3.80

mg/l

1.32

778

6500

380

3071

1.14

1.68

1.8

1.6

3.92

3.71

mg/l

0.11

288

2282

Need for other prophylactic measures

738

1.30

1.67

2.4

1.7

3.24

4.29

mg/l

0.54

531

Lumbosacral root disorders, not elsewhere classified

148

0.40

1.67

1.5

1.8

2.56

2.73

mg/l

—

116

Aortic valve malfunction, age under 60 years

105

1325

0.79

1.66

2.2

1.8

3.50

4.41

mg/l

0.71

973

Malignant neoplasm of urinary organs

841

0.73

1.66

1.5

1.6

5.51

4.55

mg/l

0.27

605

Gout, FINNGEN

217

2546

0.85

1.66

2.2

1.7

5.87

3.96

mg/l

1.49

191

1874

Other benign neoplasms of skin

547

4936

1.11

1.65

1.5

1.7

3.97

3.83

mg/l

0.09

402

3632

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

593

5375

1.11

1.65

2.0

1.7

4.17

3.86

mg/l

0.36

464

3920

Systemic atrophies primarily affecting the central nervous system

403

0.61

1.65

1.6

3.57

2.91

mg/l

0.12

306

Other diseases of stomach and duodenum

660

1.31

1.65

1.5

1.7

4.02

3.21

mg/l

0.44

483

Coxarthrosis

666

4828

0.91

1.64

1.7

4.23

3.80

mg/l

0.38

545

3495

Disorders of sclera, cornea, iris and ciliary body

1011

9384

1.08

1.64

1.7

3.88

3.93

mg/l

0.06

759

6793

Other viral diseases

834

7626

1.09

1.63

1.6

4.93

3.83

mg/l

1.31

620

5372

Cholangitis (primary sclerosing, PSC)

664

0.70

1.63

1.4

1.7

4.34

3.20

mg/l

0.33

482

Diseases of middle ear and mastoid

1276

9763

1.07

1.62

1.6

4.11

3.75

mg/l

0.58

907

6831

Other disorders of patella

369

3264

1.14

1.61

1.6

1.7

4.64

3.66

mg/l

0.90

298

2284

Granuloma annulare

223

1.56

1.61

1.4

1.7

3.93

2.76

mg/l

0.30

157

Bacterial, viral and other infectious agents

159

1317

1.22

1.60

2.0

1.8

5.89

4.38

mg/l

0.51

121

950

Parkinson's disease, including avohilmo

1131

0.78

1.60

1.4

1.7

2.00

3.76

mg/l

2.39

853

Guttate psoriasis

221

0.49

1.59

4.8

1.8

1.24

3.75

mg/l

—

164

Condition for Implicit Sepsis (Organ dysfunction codes)

1620

11836

0.94

1.59

2.0

1.6

5.63

3.59

mg/l

5.96

1292

8477

Rare circulating lymphoid malignancy, including Hilmo

286

0.55

1.58

1.3

1.7

6.71

3.21

mg/l

0.78

213

Supplementary factors related to causes of morbidity and mortality classified elsewhere

452

5036

0.89

1.57

1.6

4.50

3.86

mg/l

0.64

342

3610

Malignant neoplasm of cervix uteri, including Hilmo

372

0.61

1.57

1.7

1.6

1.98

4.79

mg/l

1.02

255

Hair colour and hair shaft abnormalities

2.51

1.56

1.3

1.6

2.26

6.19

mg/l

—

Ulcer of oesophagus

612

0.70

1.56

1.5

1.7

3.31

2.99

mg/l

0.18

452

Supervision of normal pregnancy

614

3186

1.11

1.56

1.5

1.6

4.00

4.23

mg/l

0.21

422

2351

Umbilical hernia

438

3922

1.12

1.56

1.7

5.36

3.70

mg/l

0.74

355

2868

Left ventricular outflow tract obstruction (LVOTO), broad definition

116

1434

0.80

1.55

2.2

1.7

3.58

4.39

mg/l

0.67

1053

Dialysis, with operation codes

172

1440

1.20

1.55

2.3

1.7

11.89

3.58

mg/l

4.73

160

1048

Infliximab

308

0.57

1.55

1.1

1.9

13.14

3.78

mg/l

0.43

206

Benign neoplasm of breast

199

1689

1.19

1.54

1.4

1.6

2.83

3.93

mg/l

1.33

133

1248

Chondropathies

279

2432

1.15

1.53

1.6

1.7

5.39

3.99

mg/l

0.74

206

1764

Asthma, hospital admission 2, infections

1066

9733

1.07

1.53

1.8

1.6

5.87

3.64

mg/l

6.03

872

6903

Asthma-related infections

1066

9733

1.07

1.53

1.8

1.6

5.87

3.64

mg/l

6.03

872

6903

Osteoporosis

212

2317

0.85

1.53

2.7

1.6

6.35

3.54

mg/l

1.66

178

1714

Bacterial, viral and other infectious agents

171

1434

1.20

1.53

2.0

1.7

5.66

4.48

mg/l

0.41

132

1032

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

407

0.63

1.53

1.2

1.7

5.23

2.94

mg/l

0.39

299

Hypokalaemia

108

1344

0.80

1.52

2.2

1.7

4.67

4.01

mg/l

0.21

981

Lactose intolerance

452

1.37

1.52

1.5

1.6

3.16

4.98

mg/l

0.65

314

Malignant neoplasm of corpus uteri, including Hilmo

907

0.76

1.52

1.5

1.6

4.40

3.68

mg/l

0.26

683

Thrombocytopenia, unspecified

804

0.74

1.52

2.0

1.7

10.23

3.91

mg/l

0.84

579

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1207

8541

1.07

1.51

1.7

1.6

3.69

3.82

mg/l

0.19

844

6231

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

126

0.39

1.51

1.2

1.6

8.96

3.34

mg/l

—

Parkinson's disease, strict definition, excluding more controls

971

0.77

1.51

1.4

1.5

1.83

4.18

mg/l

3.86

669

Malignant neoplasm of other and ill-defined sites, including Hilmo

128

0.39

1.50

1.4

2.0

35.96

3.52

mg/l

—

Overexertion and strenuous or repetitive movements

177

1492

1.19

1.50

1.9

1.7

5.52

4.15

mg/l

0.57

137

1076

Fracture of lower leg, including ankle

849

9070

0.92

1.50

1.6

1.7

3.67

3.80

mg/l

0.20

659

6500

Lymphoid leukaemia

465

0.66

1.50

1.4

1.6

4.02

3.14

mg/l

0.35

357

Vasomotor rhinitis (mode)

121

983

1.24

1.50

1.6

1.7

5.82

4.01

mg/l

0.69

721

Complications of internal orthopaedic prosthetic devices, implants and grafts

188

2214

0.85

1.49

1.5

1.6

3.91

3.64

mg/l

0.12

155

1628

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

546

0.69

1.48

1.5

1.7

4.27

4.36

mg/l

0.02

409

Non-ischemic cardiomyopathy

273

2517

0.87

1.48

3.9

1.6

6.43

3.72

mg/l

2.32

257

1831

Generalized epilepsy, strict definition

389

0.63

1.47

1.2

1.8

3.37

3.63

mg/l

0.12

266

Otalgia

138

1140

1.22

1.46

2.1

1.7

4.22

3.86

mg/l

0.11

105

822

Sub-endpoint used in defining T1D endpoints

402

4412

0.89

1.46

1.6

1.7

4.19

3.87

mg/l

0.30

376

3124

Colon adenocarcinoma

934

0.77

1.45

1.4

1.6

3.86

3.89

mg/l

0.01

687

Melanocytic naevi of upper limb, including shoulder

339

0.61

1.44

1.2

1.8

4.66

3.14

mg/l

0.33

247

Injury of muscle and tendon at hip and thigh level

160

1342

1.20

1.44

1.5

1.7

3.74

4.49

mg/l

0.33

114

986

Cholelithiasis, broad definition with cholecystitis

1625

10344

1.06

1.44

1.8

1.7

4.92

3.69

mg/l

2.67

1370

7494

Injuries to the ankle and foot

1567

13175

1.06

1.44

1.7

1.6

4.35

3.79

mg/l

1.25

1231

9330

Gout, idiopatic and unspecified

180

2119

0.85

1.43

2.1

1.7

6.25

4.13

mg/l

1.37

161

1561

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

516

0.69

1.43

1.6

1.7

4.37

3.93

mg/l

0.10

355

Viral hepatitis

1231

0.80

1.43

1.5

1.7

4.64

4.03

mg/l

0.29

875

Deficiency of other B group vitamins

213

1.52

1.42

1.7

1.8

3.79

2.84

mg/l

0.34

154

Nephropathy related operations

164

1380

1.19

1.42

2.3

1.7

11.26

3.86

mg/l

4.00

151

1007

Malignant neoplasm of kidney, except renal pelvis

784

0.75

1.42

1.5

1.7

5.76

4.45

mg/l

0.37

570

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

656

5957

1.09

1.42

1.6

4.16

3.84

mg/l

0.41

521

4176

Multiple delivery

135

1624

0.82

1.42

1.7

4.38

4.11

mg/l

0.07

1206

Fracture of lumbar spine and pelvis

187

2188

0.85

1.42

1.4

1.7

5.26

3.76

mg/l

0.96

140

1607

Implicit viral Sepsis

269

2353

1.15

1.42

2.6

1.6

8.31

3.62

mg/l

3.37

225

1703

Endometriosis diagnosis and infertility diagnosis occurring together

252

2198

1.15

1.42

1.5

1.6

3.93

4.01

mg/l

0.05

184

1582

Oedema, not elsewhere classified

489

4372

1.11

1.41

1.9

1.6

4.58

3.80

mg/l

0.96

406

3115

Deep endometriosis

176

1493

1.19

1.41

1.6

1.7

4.47

3.80

mg/l

0.35

128

1068

Ankylosing spondylitis, ICD10

111

1361

0.81

1.40

2.0

1.7

5.57

4.33

mg/l

0.34

986

Malignant neoplasm of cervix uteri

249

0.55

1.40

1.6

1.8

2.04

2.80

mg/l

—

176

Viral Sepsis

269

2355

1.15

1.40

2.6

1.6

8.31

3.62

mg/l

3.37

225

1704

Barrett oesophagus

493

1.33

1.40

1.6

1.8

6.85

3.25

mg/l

0.70

366

Endovascular or surgical operations to intracerebral aneurysms

747

0.74

1.40

1.4

1.7

6.99

4.44

mg/l

0.43

552

L02BX Other hormone antagonists and related agents

313

0.60

1.40

1.5

4.64

3.29

mg/l

0.34

232

Preterm labour and delivery

453

5004

0.90

1.40

1.7

1.6

4.49

3.96

mg/l

0.58

358

3668

Amputation of thigh

139

0.43

1.40

1.7

1.6

3.63

2.61

mg/l

—

112

Other viral diseases, not elsewhere classified

543

4925

1.10

1.39

1.6

1.7

4.42

3.84

mg/l

0.47

401

3496

Radiculopathy

163

1928

0.84

1.39

1.8

1.6

2.82

4.04

mg/l

1.89

139

1406

Family history of certain disabilities and chronic diseases leading to disablement

113

921

1.24

1.39

1.7

1.5

4.78

4.29

mg/l

0.13

634

Glomerulonephritis

1216

0.80

1.38

1.7

7.27

4.24

mg/l

0.92

895

Other complications of surgical and medical care, not elsewhere classified

165

1394

1.19

1.38

1.7

1.6

4.37

3.95

mg/l

0.19

131

1005

Disorders of optic nerve and visual pathways

120

1457

0.82

1.38

1.7

5.80

4.27

mg/l

0.43

1055

Oral lichen planus and hypothyroidism or thyroxine medication

215

1.51

1.38

2.1

1.9

3.77

5.04

mg/l

0.19

167

Hernia of abdominal wall

705

6506

1.09

1.38

1.7

5.56

3.71

mg/l

1.52

572

4772

Intestinal stricture

308

3476

0.88

1.38

1.6

7.04

3.70

mg/l

1.14

241

2552

Oher contracture of tendon (sheath)

2.22

1.37

1.2

1.9

2.12

4.57

mg/l

—

Other demyelinating diseases of the central nervous system

686

0.73

1.37

1.8

3.60

4.36

mg/l

0.26

491

Diabetic nephropathy

156

1294

1.19

1.37

1.7

2.1

4.79

4.77

mg/l

0.01

148

1138

Other disorders of eye and adnexa

251

2193

1.15

1.37

2.1

1.7

3.28

3.94

mg/l

0.79

194

1590

Eustachian salpingitis and obstruction

172

1461

1.19

1.37

1.6

1.8

3.11

4.22

mg/l

1.21

129

1030

Other specified and unspecified disorders of eyelid

159

1.60

1.37

1.3

2.1

4.01

2.98

mg/l

0.46

120

Right hemicolectomy

467

0.68

1.37

2.0

1.7

5.37

4.40

mg/l

0.21

364

Myopia

274

2410

1.14

1.37

1.5

1.6

4.62

3.99

mg/l

0.34

202

1695

Corneal pigmentations and deposits

0.00

1.36

0.0

1.7

—

2.99

—

Valvular operations

107

1313

0.81

1.36

2.0

1.4

3.93

4.31

mg/l

0.20

949

Postprocedural musculoskeletal disorders, not elsewhere classified

743

0.75

1.35

1.6

1.7

5.04

4.22

mg/l

0.16

556

Malignant neoplasm of mesothelium and soft tissue

370

0.64

1.35

1.9

1.7

5.54

4.60

mg/l

0.12

262

Lactose intolerance, other/unspecified

393

1.37

1.35

1.5

1.6

3.32

3.02

mg/l

0.16

282

Type 1 diabetes, strict definition, subgroup 2

0.00

1.35

0.0

1.7

—

3.70

—

Presence of cardiac and vascular implants and grafts

509

3438

1.10

1.35

6.0

1.5

4.91

3.49

mg/l

1.77

452

2494

Other assisted single delivery

403

0.66

1.35

1.1

1.9

3.85

4.34

mg/l

0.14

298

Hypertrophic disorders of skin

114

934

1.23

1.34

1.5

1.7

4.21

4.44

mg/l

0.07

669

Cervicocranial syndrome

184

1574

1.18

1.34

2.0

1.7

2.43

4.25

mg/l

2.95

139

1130

Lichen planus, including avohilmo

271

2384

1.14

1.34

1.8

1.7

5.58

3.96

mg/l

1.10

215

1780

Vascular dementia (multiple infarctions)

0.00

1.34

0.0

1.6

—

2.29

—

Macular pucker

149

1251

1.20

1.34

1.5

1.6

3.28

3.67

mg/l

0.15

109

939

Maltreatment syndromes

1009

0.79

1.34

1.7

4.67

3.97

mg/l

0.44

686

Malignant neoplasm of stomach

405

0.66

1.33

1.2

1.7

6.91

4.46

mg/l

0.44

296

Crystal arthropathies, rheuma endpoint

149

0.46

1.33

4.4

1.7

3.96

2.44

mg/l

—

117

Granulomatous disorders of skin and subcutaneous tissue

386

1.37

1.32

1.3

1.7

2.96

4.61

mg/l

0.44

279

Other arthritis (FG)

457

5032

0.91

1.32

2.0

1.6

5.37

3.62

mg/l

1.99

373

3520

Arthropathy in Crohn disease

176

0.50

1.32

1.3

1.7

3.10

3.23

mg/l

—

128

Emotional disorders starting during childhood or adolescence

114

928

1.23

1.32

1.4

1.5

4.94

3.75

mg/l

0.84

614

Fracture of neck

602

0.73

1.31

1.4

1.7

3.24

3.39

mg/l

0.06

448

Other disorders of urethra and urinary system

1344

9160

1.06

1.31

1.6

4.30

3.83

mg/l

0.75

1033

6589

Hypertensive diseases (excluding secondary)

1281

7014

1.06

1.31

1.9

1.4

5.86

3.34

mg/l

5.45

1109

4828

Arthropod-borne viral fevers and viral haemorrhagic fevers

215

2470

0.87

1.30

1.7

3.81

3.95

mg/l

0.07

161

1793

Persons with potential health hazards related to communicable diseases

786

8372

0.93

1.30

1.6

3.92

3.86

mg/l

0.05

561

5861

Pneumococcal septicemia

377

0.66

1.28

1.1

1.8

5.47

3.00

mg/l

0.81

285

Optic neuritis

712

0.75

1.28

1.3

1.7

3.16

3.81

mg/l

0.34

511

Cardiodefibrillation

358

3204

1.12

1.28

3.3

1.6

4.97

3.97

mg/l

0.72

299

2384

Persons encountering health services in other circumstances

772

7139

1.08

1.28

1.6

3.97

3.65

mg/l

0.60

612

4936

Heart failure and bmi 25plus

305

2318

0.89

1.28

3.4

1.7

6.78

4.11

mg/l

2.33

288

1840

Olecranon bursitis

669

1.26

1.27

2.2

1.8

2.33

5.05

mg/l

1.93

478

Ankylosing spondylitis, strict definition

745

0.76

1.27

2.3

1.8

6.89

3.92

mg/l

0.51

534

Metatarsalgia

171

1462

1.18

1.27

1.9

1.7

3.99

4.19

mg/l

0.10

138

1027

Perforation of tympanic membrane

110

1334

0.82

1.27

1.7

6.71

4.09

mg/l

0.79

954

Oral corticosteroids

2237

12699

1.05

1.27

2.5

1.5

6.14

3.39

mg/l

13.67

1855

8958

Vascular disorders of the intestines

506

0.71

1.27

1.6

1.7

5.41

2.56

mg/l

0.85

391

Enteropathic arthropathies

363

0.65

1.27

2.9

1.7

2.80

5.14

mg/l

0.72

254

Parkinson's disease, strict definition

993

0.79

1.26

1.4

1.7

1.83

3.73

mg/l

2.40

755

Other disorders of conjunctiva

179

1536

1.17

1.26

1.9

1.7

3.24

4.11

mg/l

0.60

131

1146

Short Achilles tendon (acquired)

398

0.67

1.25

1.9

1.7

6.81

5.25

mg/l

0.27

274

Noninfective enteritis and colitis

742

7970

0.93

1.25

1.6

4.29

3.87

mg/l

0.62

576

5705

Hypoplasia of dental enamel , including avohilmo

466

0.70

1.25

1.2

1.6

3.31

3.80

mg/l

0.25

304

Disorders of choroid and retina

1158

8729

0.94

1.25

1.7

3.81

3.92

mg/l

0.13

909

6409

Diastasis of muscle

156

1.58

1.24

1.9

2.0

2.02

3.61

mg/l

0.84

107

348

1.37

1.24

1.3

1.7

3.47

4.14

mg/l

0.40

221

Complications of other internal prosthetic devices, implants and grafts

421

0.68

1.24

1.3

1.6

4.03

4.30

mg/l

0.06

314

Sciatica+with lumbago

874

8594

0.93

1.24

1.5

1.7

4.47

3.85

mg/l

0.92

707

6171

Acute appendicitis, no complications

1194

11224

1.06

1.23

1.7

1.6

3.53

3.96

mg/l

1.17

896

8070

Cardiac arrest

674

0.77

1.23

4.3

1.4

8.49

3.72

mg/l

1.50

461

Restrictive cardiomyopathy

2.70

1.22

10.6

1.7

3.91

3.46

mg/l

—

Benign neoplasm: Stomach

119

989

1.21

1.22

1.8

1.7

7.73

3.78

mg/l

1.19

748

Explicit bacterial Sepsis

1196

0.82

1.22

1.6

8.92

3.89

mg/l

1.12

850

Primary open-angle glaucoma

219

2419

0.87

1.22

1.5

1.6

5.03

3.72

mg/l

0.55

167

1802

Sequelae of injuries of lower limb

161

1376

1.18

1.22

1.7

3.09

4.25

mg/l

0.87

134

1002

Other crystal arthropathies

142

0.49

1.22

4.4

1.7

3.96

2.57

mg/l

—

112

Amyloidosis, other/unspecified

148

1.57

1.21

1.5

1.6

4.10

3.10

mg/l

0.21

112

Sequelae of other and unspecified infectious and parasitic diseases

105

865

1.22

1.20

1.6

1.7

4.16

4.59

mg/l

0.09

637

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

984

0.80

1.20

2.0

1.7

4.11

4.01

mg/l

0.03

725

Venous thromboembolism

652

6793

0.93

1.20

1.8

1.7

4.65

3.81

mg/l

1.07

527

5006

Unknown and unspecified causes of morbidity

1017

0.80

1.20

1.6

4.75

4.16

mg/l

0.11

700

Budesonide

198

2272

0.87

1.20

1.5

3.80

3.66

mg/l

0.11

155

1598

Malignant neoplasm of endocrine gland

994

0.80

1.19

2.1

1.7

3.75

4.17

mg/l

0.17

727

Thyrotoxicosis

424

3858

1.10

1.19

2.2

1.6

3.97

3.88

mg/l

0.07

343

2824

Use of teriflunomide

198

0.54

1.19

1.3

1.9

1.97

2.99

mg/l

—

144

Fitting and adjustment of other devices

346

3467

0.90

1.19

1.6

1.5

3.55

3.67

mg/l

0.08

267

2517

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

581

5363

1.09

1.19

1.6

4.31

3.92

mg/l

0.16

437

3801

Speech and linguistic disorders

176

1457

1.17

1.18

1.5

5.20

3.66

mg/l

0.92

136

974

Primary open-angle glaucoma, strict

180

2075

0.86

1.18

1.5

1.6

5.77

3.62

mg/l

0.86

139

1546

Finngen Rheumatological endpoints

2021

12007

0.96

1.18

1.8

1.6

4.82

3.60

mg/l

4.08

1660

8387

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

1.18

0.0

1.4

—

3.77

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

570

1.28

1.18

1.6

1.7

3.48

3.69

mg/l

0.10

407

Nontoxic goitre/thyroid nodule

411

3735

1.10

1.18

1.5

1.7

3.10

3.71

mg/l

1.11

323

2764

Polyarthritis, unspecified

486

0.71

1.18

1.7

3.13

4.37

mg/l

0.41

346

Exposure to controlled fire, not in building or structure

0.00

1.18

0.0

1.7

—

3.21

—

Rheumatoid lung disease

0.00

1.17

0.0

2.1

—

2.20

—

Hereditary lymphedema

2.64

1.17

2.2

1.6

3.08

2.44

mg/l

—

Pseudopolyposis of colon

0.00

1.17

0.0

1.8

—

4.76

—

Postpartum hemorraghe, parous women as controls

651

5140

1.08

1.17

1.6

3.69

3.86

mg/l

0.22

446

3688

Unspecified acute lower respiratory infection

182

2097

0.86

1.17

1.6

1.7

8.59

4.12

mg/l

1.90

139

1510

Left side

0.00

1.17

0.0

1.7

—

4.49

—

Car occupant injured in other and unspecified transport accidents

369

3340

1.11

1.16

1.6

4.20

4.00

mg/l

0.20

291

2373

Type 1 diabetes, wide definition, subgroup 2

130

0.46

1.16

2.7

1.7

1.44

2.96

mg/l

—

Other and unspecified tonsillitis

844

6642

1.07

1.16

1.7

1.6

4.66

3.79

mg/l

1.35

631

4483

Inflammatory disease of uterus

310

2782

1.12

1.16

1.6

3.23

3.98

mg/l

1.30

250

1978

Fall on same level

2387

13558

0.96

1.16

1.6

4.10

3.80

mg/l

0.61

1862

9581

Benign neoplasm: Liver

361

1.35

1.16

1.4

1.7

4.28

3.54

mg/l

0.28

261

Family history of malignant neoplasm

223

1962

1.14

1.15

1.5

2.31

3.89

mg/l

3.70

160

1408

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

711

0.77

1.15

1.5

1.7

5.70

3.73

mg/l

0.30

526

Other juvenile arthritis

733

0.77

1.15

1.5

1.6

4.32

4.57

mg/l

0.07

488

Other CVD (FINNGEN)

122

1125

0.84

1.15

2.3

1.4

3.41

3.49

mg/l

0.04

763

Other endocrine disorders

681

0.77

1.15

1.7

1.6

3.28

4.23

mg/l

0.38

477

Premature separation of placenta [abruptio placentae]

459

0.71

1.15

1.2

1.8

5.18

4.93

mg/l

0.04

328

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

107

1284

0.83

1.15

1.6

1.7

5.61

4.21

mg/l

0.46

887

Hirsutism in women

397

1.33

1.15

1.6

1.7

4.27

3.28

mg/l

0.74

273

Carpal tunnel syndrome

993

9289

0.94

1.15

1.7

4.42

3.76

mg/l

1.29

819

6812

Accidents

1888

9038

1.05

1.14

1.7

1.6

4.34

3.70

mg/l

1.00

1426

6287

Exposure to excessive natural cold

111

0.44

1.14

1.6

1.9

2.77

3.81

mg/l

—

Benign neoplasm: Skin of upper limb, including shoulder

246

0.60

1.14

1.8

1.9

2.98

3.42

mg/l

—

188

DVT of lower extremities and pulmonary embolism

451

4906

0.91

1.14

1.8

1.7

4.98

3.96

mg/l

1.14

371

3617

Conjunctivitis (acute, non atopic)

520

4770

1.09

1.14

1.6

4.18

3.99

mg/l

0.18

401

3412

Benign neoplasm: Liver/bile ducts

388

1.33

1.14

1.4

1.7

4.87

3.63

mg/l

0.45

283

Primary coxarthrosis, bilateral

233

2636

0.88

1.14

1.8

1.7

4.62

3.82

mg/l

0.43

182

1941

Dermatitis due to substances taken internally

726

1.23

1.13

2.3

1.7

4.42

3.31

mg/l

0.81

529

Other salmonella infections

619

1.25

1.12

1.5

1.7

6.61

3.12

mg/l

0.95

433

Vitamin deficiency, wide

574

1.26

1.12

1.6

3.79

3.07

mg/l

0.40

405

Vitamin deficiency

574

1.26

1.12

1.6

3.79

3.07

mg/l

0.40

405

Specific development disorders of scholastic skills

771

1.23

1.12

1.5

1.6

5.27

3.86

mg/l

0.78

509

SLE, ICD10

492

0.72

1.12

1.5

1.7

6.63

4.57

mg/l

0.40

359

SLE, strict definition

492

0.72

1.12

1.5

1.7

6.63

4.57

mg/l

0.40

359

Diseases of the digestive system

548

5901

0.92

1.12

1.6

1.7

5.15

3.79

mg/l

0.73

430

4284

Gout, unspecified

146

1704

0.85

1.12

2.3

1.7

6.60

3.99

mg/l

1.48

133

1262

Tuberculosis, IBD comorbidity

539

0.74

1.11

2.3

1.7

13.59

2.82

mg/l

0.97

416

Small fibre neuropathy

311

1.36

1.11

1.4

1.8

3.42

2.95

mg/l

0.27

235

Drug-induced acute pancreatitis

2.50

1.11

2.4

1.5

26.38

2.13

mg/l

—

Intestinal malabsorption

628

0.76

1.11

1.9

1.7

2.53

3.91

mg/l

1.27

453

Exposure to other specified electric current

421

0.70

1.10

1.6

1.8

3.03

4.37

mg/l

0.75

297

Other abnormal products of conception

909

5655

1.07

1.10

1.7

1.6

3.60

4.02

mg/l

0.82

635

4043

Other specified/unspecified disorders of bone/cartilage

355

1.34

1.10

1.6

1.8

6.02

4.82

mg/l

0.15

266

Other and unspecified mononeuropathies, also in other diseases

329

1.35

1.10

1.5

1.8

2.57

4.65

mg/l

0.63

252

Foreign body or object entering through skin

950

0.80

1.10

1.7

2.51

4.58

mg/l

1.90

683

Other vitreous opacities

433

0.71

1.10

1.8

1.7

4.02

4.83

mg/l

0.21

329

Congenital malformations and deformations of the musculoskeletal system

218

1913

1.14

1.09

1.5

1.6

3.58

4.23

mg/l

0.67

154

1334

Diabetic neuropathy

101

833

1.21

1.09

1.5

2.1

3.01

4.65

mg/l

2.77

745

Other disorders of male genital organs

408

1.31

1.09

1.7

3.63

4.57

mg/l

0.25

289

Medicines for HER+ breast cancer

563

4938

1.08

1.09

1.7

2.81

3.73

mg/l

2.98

454

3681

Dysphagia

335

3030

1.11

1.08

1.7

1.6

5.19

3.42

mg/l

1.17

243

2170

Malaise and fatigue

860

6499

1.07

1.08

1.9

1.6

4.11

3.57

mg/l

0.75

666

4577

Malignant neoplasm of thyroid gland

937

0.81

1.08

2.2

1.7

3.98

4.18

mg/l

0.07

683

Hypermobility syndrome

126

1070

1.19

1.08

1.8

1.7

3.57

4.29

mg/l

0.47

100

746

Other protozoal intestinal diseases

357

1.33

1.08

1.5

1.7

1.32

3.35

mg/l

4.84

245

Benign leiomyoma with endometriosis

224

1982

1.13

1.07

1.4

1.7

3.76

3.89

mg/l

0.06

163

1490

Care involving dialysis

105

876

1.21

1.07

1.9

1.6

6.43

4.04

mg/l

0.88

638

COPD-related respiratory insufficiency

882

0.80

1.07

2.0

1.7

17.68

3.63

mg/l

3.69

655

Tuberculosis, wide

546

0.75

1.07

2.2

1.7

13.59

2.97

mg/l

0.95

425

Pain in limb

1683

10764

1.05

1.07

1.7

1.6

4.05

3.86

mg/l

0.35

1347

7460

Dyshidrosis [pompholyx]

263

1.39

1.06

1.5

1.8

3.55

3.68

mg/l

0.05

187

Other aneurysm

465

0.73

1.06

1.5

1.8

5.23

4.25

mg/l

0.10

348

Other diseases of blood and blood-forming organs

802

0.79

1.06

1.9

1.7

4.59

4.14

mg/l

0.17

586

Maternal care for known or suspected fetal abnormality and damage

446

3524

1.09

1.05

1.4

1.6

4.12

3.92

mg/l

0.16

309

2466

Striae atrophicae

196

1.46

1.05

1.8

1.7

2.37

3.01

mg/l

0.40

141

Delirium, not induced by alcohol and other psychoactive substances

878

0.80

1.05

1.5

1.7

4.43

4.25

mg/l

0.07

670

Carcinoma in situ of skin

606

1.24

1.04

2.5

1.7

3.73

4.06

mg/l

0.09

473

Abnormal blood-pressure reading, without diagnosis

589

1.25

1.04

1.8

1.7

2.92

3.52

mg/l

0.44

405

Keratitis

622

5793

1.08

1.04

1.6

1.7

3.67

3.97

mg/l

0.36

465

4192

Venous complications and haemorrhoids in pregnancy

392

0.70

1.04

1.4

1.7

2.13

3.46

mg/l

1.25

257

Malignant neoplasm of eye and adnexa, including Hilmo

151

0.52

1.04

4.4

1.7

4.03

2.63

mg/l

—

109

Bitten or struck by other mammals

225

1998

1.13

1.04

2.0

1.7

3.25

4.19

mg/l

1.30

165

1434

Personal history of certain other diseases

392

0.70

1.04

1.5

1.4

5.63

3.44

mg/l

0.70

263

Systemic lupus erythematosus

519

0.74

1.04

1.5

1.7

6.27

4.51

mg/l

0.35

377

Oral lichen planus, including avohilmo , including avohilmo

807

1.21

1.04

1.9

1.8

3.83

4.18

mg/l

0.14

604

Acute pancreatitis (for exclusion)

211

2383

0.88

1.03

1.5

1.7

6.16

4.03

mg/l

1.14

187

1762

Other fall from one level to another

312

3444

0.90

1.03

1.5

1.6

3.49

4.11

mg/l

0.75

220

2435

Glaucoma-related operations

428

0.72

1.03

1.3

1.7

2.24

4.41

mg/l

0.84

331

Single delivery by forceps and vacuum extractor

373

2463

0.91

1.03

1.4

1.6

3.67

4.31

mg/l

0.96

237

1775

Other and unspecified visual disturbances

155

1343

1.16

1.03

1.7

2.13

4.25

mg/l

3.96

109

987

Other symptoms and signs involving cognitive functions and awareness

607

5146

1.08

1.01

1.7

1.6

3.43

3.94

mg/l

0.84

479

3734

Other abnormal immunological findings in serum

300

1.35

1.01

1.3

1.8

9.04

3.29

mg/l

0.68

216

Atrophic disorders of skin

232

2068

1.13

1.01

2.2

1.6

4.94

4.02

mg/l

0.41

184

1527

Pre-eclampsia or poor fetal growth

654

6966

0.93

1.01

1.6

4.01

3.81

mg/l

0.31

496

4950

Infection of intervertebral disc (pyogenic)

131

0.53

1.00

2.1

1.7

1.49

2.83

mg/l

—

102

Molar incisor enamel hypoplasia

486

0.75

1.00

1.3

1.6

4.56

3.74

mg/l

0.31

317

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

0.00

1.00

0.0

2.1

—

2.51

—

Rubella [German measles]

432

1.29

1.00

1.5

1.7

2.89

5.10

mg/l

1.04

328

Faecal incontinence

121

1031

1.18

0.99

1.3

1.6

2.54

2.92

mg/l

0.49

756

Cluster headache, strict

603

1.24

0.99

1.8

1.7

2.14

4.21

mg/l

2.70

401

Other embolism and thrombosis

132

1533

0.86

0.99

1.9

1.8

4.87

4.18

mg/l

0.24

108

1124

Acute pancreatitis

211

2374

0.89

0.99

1.5

1.7

6.16

3.71

mg/l

1.45

187

1724

Other articular cartilage disorders

319

0.68

0.99

1.6

1.7

2.20

5.42

mg/l

0.99

227

Intentional self-harm by sharp object

460

1.28

0.98

2.0

1.8

5.61

3.99

mg/l

0.76

314

Other disorders of binocular vision

223

0.62

0.98

1.6

1.7

3.05

3.31

mg/l

—

144

Nontoxic single thyroid nodule

113

959

1.19

0.98

1.6

1.7

3.74

4.05

mg/l

0.13

720

Other encephalitis

377

0.71

0.98

1.1

1.8

3.93

3.57

mg/l

0.11

272

Other enthesopathy of foot (+metatarsalgia)

181

1592

1.14

0.98

2.0

1.7

3.94

4.22

mg/l

0.16

147

1122

Disease of hard tissues of teeth, NOS

1052

5809

0.95

0.98

1.8

1.6

4.40

3.42

mg/l

0.97

805

4088

Ocular pain

151

1312

1.16

0.98

2.3

1.7

3.40

4.26

mg/l

0.69

119

943

Unspecified privation

164

1433

1.15

0.98

1.7

6.83

4.20

mg/l

1.12

131

1032

Chronic lower respiratory diseases

2616

13457

1.04

0.98

1.7

1.6

5.25

3.53

mg/l

6.71

2029

9521

Haematosalpinx/Haematoma of broad ligament

0.00

0.98

0.0

1.7

—

2.83

—

Other disorders of cornea

141

1219

1.16

0.97

1.8

1.7

3.25

4.38

mg/l

0.92

106

901

Charcot foot

233

1.39

0.97

1.4

1.5

4.71

2.60

mg/l

0.70

172

Complications of genitourinary prosthetic devices, implants and grafts

318

0.68

0.97

1.5

1.7

3.27

3.04

mg/l

0.07

234

Acute generalized exanthematous pustulosis

568

1.24

0.97

2.6

1.6

4.94

4.36

mg/l

0.19

419

Care involving use of rehabilitation procedures

1075

10402

0.95

0.97

1.7

1.5

5.81

3.69

mg/l

4.76

862

7521

Caries in Clefts patients

185

0.58

0.97

1.4

1.7

2.84

3.01

mg/l

—

125

Toxic effects of substances chiefly nonmedicinal as to source

157

1796

0.87

0.97

1.6

4.60

4.24

mg/l

0.14

121

1287

Benign neoplasm: Conjunctiva

381

1.30

0.96

1.7

7.39

4.75

mg/l

0.25

292

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

452

1.27

0.96

1.8

1.7

4.29

4.31

mg/l

0.00

337

Cerebral palsy and other paralytic syndromes

127

1475

0.86

0.96

1.7

1.6

4.86

4.05

mg/l

0.51

109

1086

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

0.00

0.96

0.0

2.2

—

3.24

—

Diseases of oral cavity, salivary glands and jaws

1075

5829

0.95

0.96

1.7

1.6

4.55

3.42

mg/l

1.11

792

4105

Other acquired deformities of ankle and foot

117

0.50

0.96

1.7

1.8

3.17

4.04

mg/l

—

Phlebitis and thrombophlebitis (not including DVT)

278

3074

0.90

0.96

1.9

1.7

3.63

4.12

mg/l

0.54

227

2246

SLE (Finngen)

512

0.75

0.96

1.5

1.7

6.27

4.23

mg/l

0.42

380

Other injuries of spine and trunk, level unspecified

117

0.50

0.96

5.3

1.8

10.28

4.07

mg/l

—

Other infectious diseases

1043

0.83

0.96

2.0

1.7

9.33

3.78

mg/l

1.26

765

Dizziness and giddiness

1233

10249

0.95

0.96

1.8

1.7

3.55

3.96

mg/l

1.03

974

7445

Sudden idiopathic hearing loss

131

1128

1.17

0.96

1.7

3.46

3.82

mg/l

0.21

826

Labour and delivery complicated by umbilical cord complications

932

0.82

0.95

1.3

1.7

4.01

4.26

mg/l

0.10

676

Type 1 diabetes

403

4372

0.92

0.95

1.6

4.09

3.66

mg/l

0.44

377

3006

Congenital malformations of the urinary system

801

0.81

0.95

1.8

3.25

4.19

mg/l

0.47

571

Sequelae of injuries, of poisoning and of other consequences of external causes

404

3718

1.09

0.95

1.6

1.7

4.24

3.93

mg/l

0.20

324

2683

Other and unspecified disorders of white blood cells

466

0.75

0.95

1.3

1.7

4.78

4.52

mg/l

0.06

352

Other specified/unspecified arthritis

400

4344

0.92

0.94

2.0

1.6

5.78

3.60

mg/l

2.37

330

3042

Encephalitis

408

0.73

0.94

1.2

1.8

3.59

3.52

mg/l

0.02

297

Gonarthrosis

1159

6279

1.05

0.93

1.7

4.46

3.75

mg/l

1.10

966

4560

Unspecified mental disorder

716

7608

0.94

0.93

1.6

1.7

4.11

3.86

mg/l

0.42

606

5379

Sequelae of infectious and parasitic diseases

116

992

1.18

0.93

1.6

1.7

5.86

4.28

mg/l

0.28

734

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

2.22

0.93

1.3

1.6

2.06

1.44

mg/l

—

Hypoglycaemia, other or unspecified

103

872

1.19

0.93

2.0

1.7

3.26

4.45

mg/l

0.67

625

Varicella [chickenpox]

708

1.21

0.93

2.2

1.9

2.99

4.26

mg/l

0.94

508

Neoplasms

1935

9865

1.04

0.93

1.6

3.79

3.77

mg/l

0.02

1423

6865

Viral hepatitis, IBD co-morbidity

1027

0.83

0.93

1.5

4.40

2.74

mg/l

1.40

619

Symptoms and signs involving cognition, perception, emotional state and behaviour

1803

12774

0.96

0.93

1.8

1.6

3.57

3.97

mg/l

1.33

1420

9221

Labour and delivery complicated by fetal stress [distress]

696

4279

1.07

0.92

1.5

1.6

3.81

4.09

mg/l

0.35

488

3008

Benign neoplasm of ovary

252

2271

1.11

0.92

1.5

1.7

3.88

3.72

mg/l

0.09

182

1690

Inflammatory disorders of breast

106

1242

0.85

0.92

1.4

1.7

4.31

4.15

mg/l

0.07

870

Episcleritis

828

1.19

0.92

1.4

1.7

4.23

4.64

mg/l

0.16

599

Antepartum haemorrhage, not elsewhere classified

222

1990

1.12

0.92

1.6

1.7

3.28

4.10

mg/l

1.05

155

1400

Other hearing loss

278

2463

1.11

0.92

1.7

3.20

3.65

mg/l

0.35

212

1825

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

429

1.27

0.91

2.4

1.6

5.70

4.12

mg/l

0.46

297

Hyperlipidaemia, other/unspecified

397

3965

0.92

0.91

1.9

1.6

4.30

3.89

mg/l

0.28

331

2868

Conductive hearing loss, unspecified

129

1115

1.16

0.91

1.4

1.7

3.31

4.15

mg/l

0.60

808

Unequal limb length (acquired)

135

1.51

0.91

1.5

1.4

2.34

3.02

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

167

1472

1.14

0.91

1.8

1.6

3.12

4.22

mg/l

1.18

126

1028

Inflammatory diseases of the central nervous system

1155

0.84

0.91

1.7

4.96

4.17

mg/l

0.19

834

Benign neoplasm of other and ill-defined parts of digestive system

227

2036

1.12

0.91

1.8

1.7

5.83

3.88

mg/l

1.04

183

1509

Acute gastritis

818

0.82

0.90

2.3

1.7

3.80

3.33

mg/l

0.21

603

Other shoulder lesions

168

1481

1.14

0.90

1.9

1.7

5.32

4.25

mg/l

0.34

135

1040

Malignant neoplasm of breast, HER2-negative

690

4803

0.94

0.90

1.7

2.64

3.83

mg/l

5.22

550

3582

Spondyloarthritis

246

2725

0.90

1.8

1.7

5.34

3.97

mg/l

0.67

198

1956

Primary ovarian failure

381

0.72

0.90

1.3

1.7

3.36

mg/l

0.00

263

Other systemic involvement of connective tissue

398

3670

1.09

0.90

1.7

4.77

3.82

mg/l

0.80

323

2669

Other and unspecified glaucoma

507

0.77

0.89

1.5

1.7

2.43

4.00

mg/l

0.71

399

Accidental poisoning by and exposure to other gases and vapours

1.83

0.89

1.8

1.7

6.27

3.00

mg/l

—

Drug-induced osteoporosis with pathological fracture

156

0.57

0.89

7.9

1.9

3.13

2.39

mg/l

—

122

Benign neoplasm: Pancreas

253

0.67

0.88

1.5

1.7

2.04

2.97

mg/l

0.61

201

Torsion of ovary, ovarian pedicle and fallopian tube

378

1.28

0.88

1.8

1.6

3.96

3.74

mg/l

0.07

259

Disorders of mineral metabolism

113

970

1.17

0.88

1.9

1.7

3.31

4.18

mg/l

0.52

689

Tic and related disorders

195

1.41

0.88

1.4

1.7

3.96

3.30

mg/l

0.26

125

Inguinal hernia

874

6167

0.95

0.88

1.6

1.7

3.99

3.75

mg/l

0.22

593

4439

Other infectious diseases

869

0.82

0.87

2.1

1.6

10.69

3.76

mg/l

1.28

633

Disturbances of smell and taste

558

1.23

0.87

1.5

1.7

2.56

4.20

mg/l

0.83

402

Cluster headache, wide

631

1.21

0.87

1.8

1.7

2.13

4.06

mg/l

2.60

423

Gonarthrosis [arthrosis of knee](FG)

1356

7543

1.05

0.87

1.7

4.44

3.61

mg/l

1.68

1130

5475

Injury of nerves at wrist and hand level

586

1.22

0.87

1.8

1.7

3.44

3.88

mg/l

0.19

422

Long labour

621

4991

1.07

0.87

1.6

3.76

3.98

mg/l

0.28

457

3561

Other skin changes

233

2100

1.11

0.86

1.7

5.79

4.02

mg/l

0.78

176

1549

Oral lichen planus

317

1.31

0.86

2.4

1.7

5.24

4.76

mg/l

0.08

240

ILD medications

2458

12897

1.03

0.86

2.5

1.4

5.44

3.36

mg/l

10.37

2020

8950

Dislocation, sprain and strain of joints and ligaments at neck level

308

2817

1.10

0.86

1.6

1.7

3.55

4.13

mg/l

0.59

235

1994

Corns and callosities

791

0.82

0.86

1.6

1.7

6.64

4.59

mg/l

0.53

574

Other and unspecified injuries of shoulder and upper arm

424

0.75

0.86

2.7

1.8

3.37

5.07

mg/l

0.47

300

Haemorrhagic and haematological disorders of fetus and newborn

146

1.45

0.86

1.2

1.4

3.53

4.61

mg/l

0.21

Fourth [trochlear] nerve palsy

251

0.67

0.86

1.4

1.8

2.94

3.06

mg/l

0.03

193

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.99

0.86

1.3

1.5

2.05

1.45

mg/l

—

Congenital malformations and deformations of the musculoskeletal system

174

1536

1.13

0.85

1.5

1.6

3.56

4.37

mg/l

0.71

129

1057

Nummular dermatitis

910

0.83

0.85

1.7

2.83

3.41

mg/l

0.65

660

Iron deficiency anaemia

596

5509

1.07

0.85

1.8

1.6

4.88

3.75

mg/l

1.32

476

4040

Peripheral retinal degeneration

389

0.74

0.85

1.8

2.92

4.76

mg/l

0.52

289

Normotensive glaucoma

614

0.80

0.85

1.3

1.6

1.39

3.83

mg/l

2.09

480

Calculus of kidney and ureter

401

3711

1.08

0.85

1.6

1.7

4.37

4.00

mg/l

0.25

308

2701

Atopic dermatitis, strict definition with reimbursement

709

6462

1.06

0.84

1.6

4.01

3.63

mg/l

0.53

524

4460

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

133

1079

0.87

0.84

2.1

1.5

23.18

2.52

mg/l

6.65

116

697

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

186

1661

1.13

0.84

1.8

1.6

3.04

4.04

mg/l

1.23

144

1172

Ehlers-Danlos syndrome

258

1.34

0.84

1.9

1.7

3.38

3.23

mg/l

0.06

178

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1091

0.85

0.84

1.7

4.43

4.41

mg/l

0.01

762

Other disorders of white blood cells

667

0.80

0.84

2.0

1.6

4.04

4.17

mg/l

0.04

490

Other symptoms and signs involving the nervous and musculoskeletal systems

645

6844

0.94

0.83

1.6

1.7

3.83

3.86

mg/l

0.02

493

4965

Generalized skin eruption due to drugs and medicaments

489

1.24

0.83

2.7

1.6

5.10

3.39

mg/l

1.08

359

Hypopituitarism

114

985

1.16

0.83

1.5

1.7

4.73

4.54

mg/l

0.07

703

Vocal cord dysfunction

268

2188

1.10

0.83

2.0

1.4

3.42

3.40

mg/l

0.01

204

1395

Scleritis and episcleritis

111

958

1.17

0.83

1.5

1.7

4.16

4.36

mg/l

0.08

709

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

213

0.65

0.83

1.1

1.8

1.82

3.38

mg/l

1.96

154

Crowding of teeth, including avohilmo

160

1492

0.88

0.82

1.6

1.5

3.09

4.27

mg/l

1.13

112

1007

Redundant prepuce, phimosis and paraphimosis

297

2691

1.10

0.82

1.7

3.03

3.83

mg/l

1.05

217

1861

Flatulence and related conditions

130

1.48

0.82

1.3

1.7

2.60

3.02

mg/l

0.14

Hydrocele

110

948

1.16

0.82

1.5

1.7

5.43

4.04

mg/l

0.41

671

Abnormal findings on antenatal screening of mother

187

2086

0.89

0.82

1.5

1.6

4.43

3.88

mg/l

0.19

127

1362

Congenital malformations of genital organs

201

1795

1.12

0.82

1.7

3.76

4.00

mg/l

0.16

140

1266

Disorders of speech understanding and production

534

1.22

0.82

1.7

5.58

3.41

mg/l

0.48

366

Intracranial injury

927

9206

0.95

0.81

1.8

1.6

3.58

3.84

mg/l

0.39

717

6495

Other secondary coxarthrosis

386

0.75

0.81

1.6

1.8

8.78

4.58

mg/l

0.33

292

Excessive attrition of teeth

1167

11173

1.05

0.81

1.7

1.6

4.00

3.94

mg/l

0.06

861

8007

Open wound of shoulder and upper arm

250

1.33

0.81

1.4

1.9

6.57

4.08

mg/l

0.34

188

Use of anticholinesterases

164

1457

0.89

0.81

1.5

1.6

2.52

3.49

mg/l

0.74

125

1114

N06DA Anticholinesterases

164

1457

0.89

0.81

1.5

1.6

2.52

3.49

mg/l

0.74

125

1114

Nausea and vomiting

413

3757

1.08

0.81

1.7

1.6

4.98

3.52

mg/l

1.47

347

2603

Open wound of head

780

7926

0.95

0.81

1.8

1.6

4.63

3.84

mg/l

0.85

598

5647

Acute peritonitis

675

0.81

1.7

4.13

4.37

mg/l

0.06

500

Tuberous sclerosis 1

0.00

0.80

0.0

2.2

—

3.04

—

Histrionic personality disorder

1.71

0.80

1.5

1.8

3.60

2.32

mg/l

0.35

Relapsing polychondritis

0.00

0.80

0.0

2.2

—

2.63

—

Severe mental retardation

0.00

0.80

0.0

1.5

—

4.43

—

Other leukaemias of specified cell type

0.00

0.80

0.0

1.5

—

3.67

—

Traumatic amputation of ankle and foot

0.00

0.80

0.0

1.8

—

4.43

—

Superficial injury of abdomen, lower back and pelvis

256

2331

1.10

0.80

1.6

1.7

4.70

4.01

mg/l

0.44

195

1661

Disorders of plasma-protein metabolism, not elsewhere classified

1.56

0.80

1.9

1.8

18.75

3.41

mg/l

1.20

Abnormalities of forces of labour

234

2123

1.11

0.80

1.6

1.7

2.98

4.09

mg/l

1.74

182

1569

Drug-induced myopathy

0.00

0.80

0.0

1.3

—

3.86

—

Zoster [herpes zoster]

713

6637

1.06

0.80

2.0

1.6

4.70

3.73

mg/l

1.19

540

4838

Cyclic neutropenia

0.00

0.80

0.0

1.6

—

2.71

—

Contusion of other and unspecified parts of foot

902

0.84

0.80

1.7

4.23

4.62

mg/l

0.15

628

Urolithiasis

423

3934

1.08

0.80

1.6

1.7

4.29

4.03

mg/l

0.17

324

2865

Nutritional anaemias

686

6246

1.06

0.80

1.9

1.6

4.82

3.74

mg/l

1.41

554

4566

Other superficial mycoses

203

1828

1.12

0.80

1.4

1.7

3.20

4.15

mg/l

1.07

138

1284

Noise effects on inner ear

441

0.77

0.80

1.5

1.7

2.64

4.78

mg/l

1.15

323

Antenatal screening

615

3247

1.07

0.80

1.5

1.6

3.69

4.22

mg/l

0.71

428

2396

Other diseases of intestine

180

1609

1.12

0.79

1.8

1.7

6.88

3.36

mg/l

1.73

142

1177

Ankle and foot

122

0.56

0.79

2.0

2.1

5.91

2.98

mg/l

—

Synovial cyst of popliteal space [Baker]

848

0.83

0.79

1.9

1.6

6.44

4.59

mg/l

0.38

603

Purpura and other haemorrhagic conditions

152

1714

0.88

0.79

1.9

1.7

6.07

4.18

mg/l

0.57

118

1244

Inflammatory disease of cervix uteri

804

1.18

0.79

1.7

3.45

3.87

mg/l

0.18

597

Tic disorders

182

1.39

0.79

1.4

1.8

2.91

2.94

mg/l

0.01

118

Benign neoplasm of middle ear and respiratory system

102

878

1.17

0.79

1.8

1.7

4.21

4.45

mg/l

0.06

642

ILD medications: pirfenidone

1.61

0.79

2.7

1.4

67.89

2.75

mg/l

2.65

Varicella [chickenpox]

804

1.18

0.79

2.2

1.8

2.98

4.27

mg/l

1.08

578

Use of levodopa decarboxylase inhibitor

924

0.84

0.79

1.4

1.7

2.97

3.71

mg/l

0.42

710

Atopic conjunctivitis

713

1.19

0.78

1.4

1.7

3.94

4.62

mg/l

0.30

513

Hypotension due to drugs

0.50

0.78

3.4

1.5

7.72

2.79

mg/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

966

0.85

0.78

1.9

1.7

4.71

3.93

mg/l

0.17

725

Malignant neoplasm of thyroid gland, including Hilmo

1083

0.85

0.78

2.1

1.7

3.61

4.12

mg/l

0.24

795

Ulcer of oesophagus, drug-induced

0.00

0.78

0.0

1.7

—

4.77

—

Prominent ears

183

1.39

0.78

1.2

1.5

2.98

3.71

mg/l

0.28

113

Other orthopaedic follow-up care

741

1.18

0.78

1.6

4.99

4.33

mg/l

0.25

532

Other congenital malformations of face and neck

483

0.78

0.77

1.5

1.8

4.42

3.56

mg/l

0.25

341

Traumatic subarachnoid haemorrhage

349

0.74

0.77

2.7

1.7

2.39

4.08

mg/l

0.89

244

Other parasitologically confirmed or unspecified malaria

1.81

0.77

1.7

1.6

32.67

3.25

mg/l

—

162

0.61

0.77

2.1

1.7

8.72

2.58

mg/l

—

125

Stomatitis and related lesions

326

3008

1.09

0.77

1.8

1.6

3.70

4.05

mg/l

0.34

236

2161

Congenital lens malformations

1.68

0.77

1.5

1.8

3.68

4.78

mg/l

—

Malignant neoplasm of uterus, part unspecified, including Hilmo

0.00

0.77

0.0

2.0

—

1.62

—

Allergic contact dermatitis due to drugs in contact with skin

297

1.29

0.76

1.4

1.8

3.51

3.33

mg/l

0.05

220

Amyloidosis

183

1.38

0.76

1.5

1.7

4.96

2.97

mg/l

0.48

143

Mesial bite

158

1.42

0.76

1.2

1.7

2.09

3.14

mg/l

0.95

106

Arthropathy in ulcerative colitis

220

0.67

0.76

3.9

1.8

2.39

3.00

mg/l

0.34

164

Nephrotic syndrome

370

0.75

0.76

1.3

1.7

8.26

3.04

mg/l

0.54

277

Contact with machinery

114

1305

0.87

0.76

1.6

1.7

5.03

3.78

mg/l

0.34

940

Ectopic pregnancy

354

3281

1.08

0.76

1.6

1.7

3.23

3.90

mg/l

0.96

261

2410

Aortic aneurysm

174

1904

0.89

0.76

1.6

1.7

3.19

4.33

mg/l

1.01

139

1406

Speech disturbances, not elsewhere classified

887

0.84

0.76

2.3

1.7

4.33

3.77

mg/l

0.21

660

Malignant neoplasm of breast

709

4882

0.95

0.76

1.7

2.66

3.81

mg/l

5.11

564

3638

Paralytic ileus and intestinal obstruction

263

2871

0.91

0.76

1.5

1.6

7.03

3.60

mg/l

0.95

199

2071

Malignant neoplasm of oral cavity

347

0.74

0.76

1.3

1.8

2.90

3.27

mg/l

0.13

252

Congenital malformations of the urinary system

864

0.84

0.75

1.7

3.08

4.07

mg/l

0.56

617

Exposure to other and unspecified animate mechanical forces

525

0.79

0.75

1.7

1.8

4.09

4.81

mg/l

0.17

361

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

432

1.24

0.75

1.8

1.7

4.55

4.28

mg/l

0.05

323

Infections of genitourinary tract in pregnancy

166

1853

0.89

0.75

1.5

1.6

3.19

3.88

mg/l

0.64

120

1271

Congenital malformations, deformations and chromosomal abnormalities

1415

12553

1.04

0.75

1.6

4.03

3.83

mg/l

0.29

1016

8950

Fracture at wrist and hand level

564

5972

0.94

0.75

1.7

1.6

3.53

3.97

mg/l

0.44

416

4208

Suicide or other Intentional self-harm

488

4577

1.07

0.75

1.6

1.7

4.53

3.91

mg/l

0.89

418

3275

Biological medicines for asthma

316

1.28

0.75

1.5

1.7

4.40

3.39

mg/l

0.41

220

Injuries to the neck

424

3958

1.07

0.75

1.7

3.46

4.01

mg/l

0.74

324

2802

Benign neoplasm: Pituitary gland, craniopharyngeal duct

744

0.83

0.75

1.7

3.50

4.50

mg/l

0.47

543

Vitreous haemorrhage

125

1098

1.14

0.75

1.7

3.40

4.27

mg/l

0.61

103

806

Papillary adenocarcinoma of thyroid gland

722

0.83

0.75

2.2

1.7

3.82

4.08

mg/l

0.08

525

Benign neoplasm of brain and other parts of central nervous system

809

0.84

0.74

1.6

1.7

4.71

3.81

mg/l

0.20

582

Frostbite

134

0.59

0.74

1.4

1.8

3.98

4.42

mg/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

350

3246

1.08

0.74

1.6

1.7

4.45

4.04

mg/l

0.42

299

2301

Specific development disorders of speech and language

102

851

1.16

0.74

1.6

5.01

3.72

mg/l

0.41

573

Vitamin B12 deficiency anaemia

105

911

1.16

0.74

1.8

1.7

4.82

3.53

mg/l

0.48

682

Hereditary lymphedema

2.07

0.74

2.2

1.6

3.08

2.48

mg/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS